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Abstract 
Magnetically Targeted Drug Delivery: 
Contributions In Magnetic Nanoparticle Uptake And Manipulation 
Cristin Marie MacDonald 
Currently, there are multiple approaches to targeted therapies being researched that 
involve the use of magnetic micro/nanoparticles. Their high biocompatibility as a result of 
magnetite’s composition and the ability to position the magnetite in biocompatible 
polymer coatings such as PLA and PLGA makes them a potential resource for cancer 
treatment and gene delivery. Magnetic targeting utilizes an external magnetic field in 
combination with MNPs to allow delivery of particles to the desired target area and 
fixation to a local site while the medication is released and acts locally.  This technique 
allows for decreased dosage of chemical therapies that may otherwise cause deleterious 
systemic effects.  While much work has been completed on functionalizing MNPs and 
targeting them in vitro, there is minimal work that examines how these MNPs can move 
through soft tissues to treat disease.   
Our work uses an alternating magnetic field, applied perpendicularly to a static 
magnetic gradient to increase magnetic nanoparticle motion through a simulated soft 
tissue.  In order to increase magnetic susceptibility highly superparamagnetic 
nanoparticles were synthesized with magnetite concentrations of up to 70% (w/w).  We 
found that magnetic nanoparticle uptake is a force dependent process and that an 
increase in MNP magnetite concentration not only leads to an increase in magnetic force 
applied to the cell but also increases MNP uptake.  Using this process we were able to 
load bovine aortic endothelial cells with up to 15% of their cell volume without any 
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deleterious effects to the cytoskeletal or mitochondrial function. As a result of the 
minimal toxic effects, we tested the ability to manipulate the movement of loaded cells 
and showed that under the influence of a magnetic gradient from a permanent magnet 
there was significant increase in MNP loaded cell migration through a collagen coated 
transwell membrane in comparison to control cells.  The loaded cells offer less toxic 
magnetically targeted vectors with a much higher magnetic susceptibility in comparison 
to MNPs alone.  Further research is needed to determine if the “shaking” effect exhibited 
in the MNP viscous fluid study would work with MNP loaded endothelial cells. 
 This thesis analyzes magnetic nanoparticle synthesis with varying magnetite 
incorporation and how these differences affect magnetic nanoparticle motion with and 
without an alternating magnetic field.  Through this research it has been found that we 
can load magnetite crystals into polymer nanoparticles up to 70% w/w without affecting 
the structural integrity of the particle.  As a result, the particles synthesized were on 
average 250 nm in diameter and were significantly more responsive to external magnetic 
fields in comparison to standard commercially available nanoparticles that are 
approximately 30-40% w/w.  The increase in magnetic responsiveness yields an 
increase in magnetic nanoparticle velocity through a viscous fluid, under the influence of 
a magnetic field provided by a neodymium magnet.  The velocity in which particles 
moved increased linearly with respect to the amount of magnetite incorporated into the 
particle.  The addition of the alternating current field that was applied perpendicular to 
the line of movement allowed the leading edge of the MNP group to move a 10 mm 
distance more quickly than the static only group.  Additionally, the MNPs exposed to the 
alternating current field, also had an increase in the percentage of particles that made it 
the entire 10 mm length. 
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 The increase in magnetic responsiveness was also examined when loading 
MNPs into bovine aortic endothelial cells (BAEC).  It was found that an increase in 
magnetite concentration led to an increase in magnetic nanoparticle uptake into BAEC.  
This effect was determined to be a function of the magnetic force applied to 
nanoparticles since MNP uptake was minimal without the influence of a magnetic field.   
 Lastly, these highly loaded magnetic cells were used in two dimensional and 
three dimensional migration assays to determine if the MNP loadings had any positive or 
negative effects on migratory function.  In two-dimensional studies, it was determined 
that highly loaded BAEC were not inhibited from migrating.  In fact, 10% and 70% MNP 
loaded cells experienced migration rates that were significantly higher than that of the 
control, while 30% MNP loaded cells exhibited a higher migration rate that was not 
statistically significant.  This implied that the functionality of the cytoskeleton for its role 
of migration was not impaired by the presence of the MNPS.  The addition of a magnetic 
field, resulting from a neodymium magnet was added to 3-D migration in order to 
determine if MNP loaded BAEC would migrate through a Boyden chamber more quickly 
than non-loaded BAEC.  It was found that the 70% MNP loaded BAEC were able to 
migrate across the membrane at speeds equal to that of control cells that were 
encouraged to migrate through the membrane with the assistance of FBS gradients.  
This study showed successful implementation of MNP loaded cell movement 
manipulation through a membrane. 
 The overall study has shown that increased magnetite concentration in polymer 
MNPs yields higher MNP uptake into endothelial cells.  The increased MNP 
concentration in the cytoskeleton of the endothelial cells allows for an increase in 
magnetic responsiveness.  The increase in MNP concentration shows minimal cellular 
function impairment.  The ability to load these cells and manipulate them through the 
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body with minimal deleterious effects to their functionality makes them excellent 
candidates as vehicles for gene, drug or cellular deliveries. 
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Chapter 1: Background and Introduction 
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1.1  Thesis Overview 
Biocompatible magnetic micro/nanoparticles are currently being developed as 
targeted drug and gene delivery agents, magnetic resonance imaging contrast agents and 
as thermoablation mechanisms.  The potential of magnetic micro/nanoparticles for these 
applications results from their small size (comparable to a cell (micro) or protein (nano)), 
their biocompatibility, and most importantly their ability to be directed to a specific site 
through the use of an applied magnetic field gradient. However, the potential of magnetic 
particles for medical applications has not been fully realized due to limitations in the 
capability to accurately control the movement of the particles in vivo and to adequately 
concentrate the particles at the target site.  
For example, the use of magnetic particles for thermoablation of cancerous tumors 
has been limited by the inability to move the particles within the tumor in order to obtain 
a homogeneous distribution and uniform heating. For many applications the magnetic 
particles must migrate through soft tissue under the influence of an applied field to reach 
the desired location. A better understanding of the factors that influence the movement of 
magnetic nanoparticles (MNP) through soft tissue is required to fully exploit the potential 
of these particles. Surprisingly little work has been performed on this important aspect of 
the overall problem.   
Magnetically loaded cells have also been investigated as potential targeted delivery 
vectors that would allow circumnavigation of the immune system, as well as increase the 
magnetic susceptibility of the vector.  Loading a cell with therapeutics attached to the 
MNPs or genetic materials to deliver genetically altered cells to specific areas are two 
potential ways that targeted drug delivery can be improved.  In order to determine the 
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feasibility of this option, it is important to determine how these particles enter into a cell.  
In the past, work has been performed that shows an increase in transfection in cells with 
nanoparticles as gene delivery vectors; however, the mechanism of uptake is still 
unknown due to the difficulties in eliminating one endocytotic pathway without affecting 
another.  Lastly, the uptake of these particles must be examined due to their cytotoxic 
effects.  MNPs have been shown to be toxic both in vivo and in vivo and size and 
concentration both influence the toxic effects these particles exhibit. 
In support of these concepts, this thesis contains a series of studies that address 
various important questions relevant to making magnetically targeted drug delivery one 
step closer to incorporation in a clinical setting.  This thesis analyzes magnetic 
nanoparticle synthesis with varying magnetite incorporation and how these differences 
affect magnetic nanoparticle motion with and without an alternating magnetic field.  The 
thesis takes the first step in analyzing magnetic transport through soft tissues by looking 
at the cellular level how MNPs of various iron oxide concentrations enter a cell, affect 
cell function and health as well as a feasibility study involving three-dimensional 
migration of particle loaded cells.  The specific aims of this work are: 
• Chapter 2: Synthesize magnetic nanoparticles of varying magnetite 
concentrations and examine how their motion through a viscous fluid is 
affected by a time-varying magnetic field. 
• Chapter 3:  Determine whether the mechanism of uptake is force driven and 
clarify the effects of cholesterol depletion and cytochalasin-D on uptake to 
offer a potential uptake mechanism.  Quantify particle loading in cells. 
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• Chapter 4:  Determine whether toxic effects of high MNP loadings affect 
mitochondrial function, cytoskeletal function and test magnetically loaded 
cells to determine if a magnetic force will increase cell migration through a 
membrane. 
This thesis advances the knowledge in magnetically targeted drug delivery by 
offering a synthesis process that allows high incorporation of magnetite into magnetic 
nanoparticles yielding significantly more magnetically responsive particles.  It looks to 
show that the major endocytotic mechanism of particle uptake is force-dependent and the 
result is cells that are extremely highly loaded.  Further clarification of MNP toxicity of 
such high loaded cells as well as how we can manipulate their movement under the 
influence of a magnetic field. 
1.2 Superparamagnetic Nanoparticles 
1.2.1 Nanoparticles 
Nanoparticles have been in existence long before nanotechnology research began.  
A Roman piece of art known as the Lycurgus Cup has been in existence since the 4th 
Century AD and recent analysis has shown the presence of silver and gold nanoparticles 
on the surface of the cup[1]. Nanoparticles are small particulates with at least one 
dimension on the scale of one billionth of a meter.  Nanoparticles can be further divided 
into fine nanoparticles, comprised of particles 1-100 nm and superfine nanoparticles, 
comprised of particles 100-1000 nm.  Nanoparticles can currently be made of different 
materials, sizes and shapes and have various coatings, chemical and surface properties.  
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Currently, some of the most common nanoparticles are carbon nanotubes, nanoshells, 
quantum dots, spherical nanoparticles and nanorods [2]. 
1.2.2 Superparamagnetism 
Superparamagnetism is a property only observed in small ferromagnetic particles.  
One of the unique properties of nanoparticles is that they behave very differently from 
bulk or thin film stocks.  When particle size is reduced below 15-20 nm, particles no 
longer exhibit ferromagnetic behavior, indicating that once a magnetic field is removed, 
the particles do not exhibit permanent magnetization.  Despite the lack of permanent 
magnetism, nanoparticles still exhibit strong paramagnetic properties with large magnetic 
susceptibilities, which is the materials magnetic response to an applied magnetic field. 
The difference in electron spin alignment of nanoparticles is what makes them 
superparamagnetic as opposed to ferromagnetic.  Ferromagnetic materials have unpaired 
electrons that align themselves spontaneously.   Therefore, without the influence of an 
external magnetic field, they still show magnetization.  This magnetization is present 
even upon removal from a magnetic field.  A change in external magnetic field direction 
while initially opposed, eventually will lead ferromagnetic fields to switch directions, 
Figure 1.1 [3]. 
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Figure 1.1: Ferromagnetism magnetic moments in a material are aligned parallel to one 
another under the influence of a magnetic field.  These moments remain parallel when a 
magnetic field is not applied.  Paramagnetism magnetic moments in a material are 
randomly oriented due to thermal fluctuations when there is no magnetic field. In an 
applied magnetic field, these moments will align parallel to the field so that the 
magnetization of the material is proportional to the applied field. [4] 
 
When ferromagnetic materials reach particle dimensions smaller than a particular 
domain, they are no longer ferromagnetic and are called superparamagnetic [5].  In the 
case of paramagnetic particles, a magnetic field causes magnetic moments within the 
particles to align, causing them to have a magnetization, figure 1.1. However, unlike 
ferromagnetic materials, upon removal from the magnetic field, the magnetization returns 
back to zero.  
 What characterizes a particle as Superparamagnetism is a result of non-
interacting, thermally fluctuating nanoparticle moments where the particle volume 
dependent effective anisotropy energy (KV) of each particle is easily overcome by the 
thermal energy (kaT)[5].  The result, as stated before is nanoparticles with a high 
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saturation magnetization but magnetization (M)- field (H) curve that shows no hysteresis, 
remanence or coercivity, Figure 1.2. 
 
Figure 1.2:  M-H curves of ferromagnetic material show hysteresis.  Paramagnetic M-H 
curves show no hysteresis, but a long build up to saturation magnetization whereas 
superparamagnetic materials reach saturation magnetization quickly in comparison [6]  
The difference between superparamagnetic as opposed to paramagnetic is the 
external field required to reach magnetization saturation. Superparamagnetic particles 
require minimal external field to reach magnetization saturation, whereas paramagnetic 
particles need the maximal external magnetic field strength to reach magnetization 
saturation, figure 1.2. 
1.2.3 Superparamagnetic Nanoparticle Synthesis  
Variations in synthesis methods lead to different size, shape and distribution of 
nanoparticles.  The most important aspect of choosing a synthesis process is the ability to 
control the necessary nanoparticle characteristics for the intended application. 
Superparamagnetic nanoparticles can be synthesized via chemical methods (co-
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precipitation, microemulsions, hydrothermal, thermal decomposition, sol-gel, polyol, 
sonochemical or electrochemical deposition), physical methods (flow injection, aerosol, 
pulsed laser ablation, laser induced pyrolysis or powder ball milling) or biological/bio-
mineralization methods[7, 8].  Additional methods or alterations of current methods, in 
order to better control superparamagnetic nanoparticle characteristics, are being created 
daily as the field of nanotechnology grows. 
Most of these methods fit into one of two categories: “top down” or “bottom up” 
approach.  The top down approach involves taking a solid and breaking it down into 
smaller segments via milling, chemical methods or volatilization followed by 
condensation.  The second approach, bottom up, involves synthesis of nanoparticles via 
condensation of materials in a gas phase or in solution, such as co-precipitation or 
emulsions[9].   
The most common category used for superparamagnetic nanoparticle synthesis 
for biological applications is the bottom up approach. MRI based uses of MNPs use 
aqueous co-precipitation in the presence of the coating material as the synthesis method 
of choice[10].  Our research happens to use a modified version of this technique to create 
our MNPs, figure 1.3 [11-13].  
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Figure 1.3:  Modified Magnetic Nanoparticle Synthesis via a standard inverse 
microemulsion method. 
 
Magnetite was formed following the chemical synthesis described: 
         2 FeCl3  · 6 H2O  +  FeCl2· 4 H2O + 8 NaOH   Fe3O4  + 8 NaCl  + 20 H2O     (1) 
The resulting MNPs were coated with oleic acid as a stabilizer.  A standard inverse 
microemulsion method was then used with PVA as a surfactant.  One of the unique 
aspects of magnetic nanoparticles is that the percentage of magnetite within the 
nanoparticles can be altered [13].  Our research was unique in looking at  MNPs with 
diameters of 250 nm varying magnetite concentrations and characterizing the resulting 
properties of the particles. 
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1.3 Applications of Superparamagnetic Nanoparticles in Biomedical 
Sciences and Medicine 
Superparamagnetic nanoparticles such as the ones we have created have been 
used for biomedical applications and in medicine for more than thirty years [14].  The 
unique properties they display such as paramagnetism and inherent biocompatibility, due 
to the fact that they break down into iron and oxygen, make them attractive options for 
different functions in medicine.  Some of their current and future uses in medicine are 
magnetic resonance imaging, hyperthermia, drug and gene delivery, cell separation and 
purification and tissue engineering [15]. 
1.3.1 Coating and Functionalization of Superparamagnetic Nanoparticles  
Functionalization or coating magnetic nanoparticles is helpful in that it allows 
attachment of drugs, DNA or active binding sites as well as helps to protect the magnetite 
from degradation within the body [16].  Coatings of magnetic nanoparticles can be 
materials such as silver and gold or natural or synthetic polymers.   Some commonly used 
natural polymers are dextran, albumin, alginate, chitosan, RGD and lipids.  Examples of 
synthetic polymers are polyethylene glycol (PEG), polylactic co-glycolic acid (PLGA) 
and polyvinyl alcohol (PVA) [16].  These polymer coatings allow easier attachment of 
drug, DNA, fluorescent labels or active binding sites, due to the presence of a free end 
group or the ability to incorporate them into the matrix.  The attachment of these 
therapeutic agents can be permanent (e.g. covalent bonding), or can be altered so that 
they are released with degradation of the polymer or MNP (e.g. encapsulation in particle). 
For magnetic resonance imaging (MRI) purposes, dextran and PEG coatings on 
magnetic nanoparticles were found to be useful as they increased the longevity of 
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magnetite particle functioning circulation time in blood[17].  Similarly, MNPs for MRI, 
hyperthermia, drug delivery tissue engineering, and cell separation will often have 
monoclonal antibodies or peptides linked to the surface of the particle to detect cells of 
certain cancers[18]. 
1.3.2 Magnetic Nanoparticles in MRI 
Magnetic nanoparticles, from 3-10 nm were first used in MRI as contrast agents 
for spleen and liver tissue imaging as a result of the particles tendency to accumulate 
reticuloendothelial system [19].  However, modern MRI techniques use contrast agents to 
improve signal intensity while differentiating diseased tissue, tumors, inflammation and 
microscopic blood vessels[20].  Traditional paramagnetic contrast agents for MRI are 
manganese (Mn2+), iron (Fe3+) or gadolinium (Gd3+)[20].   
Iron particles offer some advantages of manganese or gadolinium commercially 
available contrast agents, firstly, in that iron nanoparticles have higher circulation times 
throughout the body.[21] Secondly, iron nanoparticles exhibit less toxicity than 
manganese and gadolinium particles, which have been shown to cause fetal toxicity in the 
cardiovascular system, central nervous system, lung and liver and cause serious kidney 
damage. This toxicity precludes the usage of manganese or gadolinium in patients with 
any pre-existing conditions that may have weakened any of these toxic-prone systems [22, 
23].  Lastly, the ease at which we can functionalize magnetic nanoparticles also makes 
them more attractive in comparison to the other contrast agent types, as the particles can 
then perform as both diagnostics and therapeutics with the application of one dose. 
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1.3.3 Magnetic Nanoparticles in Hyperthermia  
In addition to magnetic nanoparticle clinical uses in vivo, they are also currently 
being clinically investigated potential hyperthermia treatments in oncology. Traditional 
hyperthermia methods today are radiofrequency, microwave, ultrasound and whole body 
hyperthermia.  For magnetic nanoparticle hyperthermia, the magnetic nanoparticles are 
exposed to an alternating field, which in turn cause the magnetic moment inside of the 
particle to oscillate; the energy caused from these oscillations is released in the form of 
heat. Temperature increases up to 56°C will cause thermalablation, demonstrated by 
necrosis, coagulation or carbonization of the surrounding tissue [24].  In hyperthermia, 
the tissues surrounding the nanoparticles are heated from 41-46°C[25, 26].  While this 
temperature increase in not sufficient to completely kill cancer cells, it does however 
make cancer tissues susceptible to treatment and allows healthy tissues to recover, 
whereas thermalablation would non-selectively kill both types of tissue.   Therefore 
particles functionalized with drug treatments would be a benefit in magnetic 
hyperthermia, since the release of the drug would completely kill already weakened 
cancer cells[27]. 
Work first began on magnetic nanoparticle hyperthermia in lymph nodes with 
Gilchrist, et al. in the late 1950s [28].  Today, there are many pre-clinical trials in 
progress regarding magnetic nanoparticle hyperthermia [29] and the first clinical trial was 
performed in prostate cancers at the Charite´ University Medicine in Berlin, Germany in 
the early 2000s[30].  While hyperthermia is an attractive option, there are still issues such 
as homogeneity of heating throughout the tumor and the ability to reach deep areas of the 
tumor. While magnetic nanoparticle hyperthermia can potentially help to reach deep 
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areas of the tumor, more work is still necessary to determine how to get a homogeneous 
disbursement of magnetic nanoparticles in order to allow even heating throughout the 
tumor. 
1.3.4 Magnetic Nanoparticles in Tissue Engineering  
There have been very few published works that investigate how magnetic 
nanoparticles can be useful in tissue engineering applications, however, those that have 
been published show that there are many potentially useful purposes for their inclusion in 
standard tissue engineering procedures.  Ito et al. was the first to use magnetic 
nanoparticles to create in-vivo simulated tissues consisting of various cell types [31].  
This work used magnetic nanoparticles in magnetic cationic liposomes (MCLs) loaded 
into human aortic endothelial cells (HAECs) to create layers of tissue.  HAECs that were 
not loaded with MCLs were seeded on a layer of rat hepatocytes in an attempt to get them 
to form an attached layer of cells, however, no attachment occurred.  On the other hand, 
MCL loaded HAECs in the presence of a magnetic field did attach to the rat hepatocytes, 
forming a co-cultured tissue layer.  Similarly, Perea et al. used clinically approved 
magnetically loaded human umbilical vein endothelial cells (HUVECs) in the presence of 
a magnetic field to form an endothelial cell lining on the surface of a vascular conduit 
(cite)[32].   
Work at Drexel University shows similar results as shown previously.  
Buyukhatipoglu et al. showed that alginate and magnetically loaded porcine aortic 
endothelial cells were able to be successfully printed and the resulting three-dimensional 
(3-D) structure could be altered by magnetic fields that moved the nanoparticles and 
magnetically loaded cells[3, 33, 34].  The ability to move the magnetic nanoparticles 
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within the 3-D structure was important in realizing the potentials of moving bioactive 
factors throughout the system after printing, which would be important in helping to 
create 3-D printed tissues or organs.  Similarly, work in the Polyak lab has recently begun 
in creating magnetic nanoparticle incorporated scaffolds that when combined with a 
magnetic field and magnetically loaded cells, helps to encourage cell seeding within the 
scaffold.  The magnetic scaffolds when used in the presence of an AC field can also be 
used to deliver bioactive agents or stimulate growth as the contraction and expansion of 
the scaffold can be altered to release drug or stimulate growth in cells that are mechano-
sensative (eg. Bone[35]). 
While most of the above work investigates organization of cells to form tissues, 
other tissue engineering work shows how MNPs can be used to encourage cell 
differentiation. Kanczler et al., showed that by tagging mechosensative receptors with 
magnetic nanoparticles on the cell membrane of human bone marrow stromal cells 
(HBMSCs), they were capable of activating differentiation in vitro and in vivo towards 
osteochondral lineage[36].  This work represents another promising function of magnetic 
nanoparticles in tissue engineering applications. 
1.3.5 Magnetic Nanoparticles for Cell Separation and Purification 
Magnetic nanoparticles have been used to separate cells, proteins and other 
biomolecules [37].  In magnetic separations, the MNPs are functionalized to attach to 
whatever material being separated and a magnetic field is applied, separating the desired 
material from the bulk suspension. Superparamagnetic nanoparticles are idea agents for 
biological separations since exposure to a magnetic field attracts them and they can then 
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be easily re-suspended once removed from that field, in contrast to liquid 
chromatography systems which are expensive and have extensive set up times.   
1.3.6 Magnetic Nanoparticles in Gene and Drug Delivery 
The ability of superparamagnetic nanoparticles to target and penetrate specific 
organs and cells contributes to their toxicity, however, under controlled situations, this 
functionality can be exploited for pharmacological treatment.  Gene delivery occurs via 
viral vector delivery systems, or the increasingly used safer non-viral methods[38, 39].   
Gene transfection, utilizing viral and non-viral vectors functionalized with surface 
proteins for cellular uptake and targeting ligands, exhibits slow accumulation which leads 
to small vector concentrations in the target tissues[40].   
Magnetic nanoparticle assisted transfection, i.e. magnetofection, increases DNA 
vector accumulation within a cell in comparison to non-magnetically assisted methods.  
In vitro models show that magnetofection accelerates the transfection kinetics and the 
largest fraction of the dose is available in as little as ten minutes of incubation with cells, 
in comparison to the two and four hours it typically takes with non-magnetic 
protocols[41]. In-vivo models required targeting of desired tissue prior to tranfection and 
was completed by functionalization of the surface of the MNPs with the respective 
targeting ligands[41].  To test the feasibility and efficiency of magnetic non-viral vectors 
in comparison to viral vectors, Scherer,et al. used a rat and mice model, applying vectors 
to the ilea lumens or the stomach lumens, respectively along with a magnetic field. 
Scherer’s group reported that magnetofection of non-viral vectors was equally as 
successful as its more toxic viral vector counterparts.  
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Magnetically targeted drug delivery typically focuses on cancer related treatments, 
since chemotherapy agents are not selective towards cancerous tissues and therefore 
deleterious to the healthy tissues as well[42].  The benefits of magnetically targeted drug 
delivery for cancer is that they allow these strong drugs to be delivered to only the cancer 
affected area, leaving the remainder of the tissues in the body unscathed from their toxic 
effects.  Most importantly, smaller doses can be used if they are delivered right to the 
affected area.  
Magnetically targeted drug delivery has been proven successful in small animal 
models [43, 44], however, the translation of these models into clinical settings, is difficult 
as a result of the size difference.  Magnetic fields decrease exponentially with distance; 
therefore it takes a much stronger field to direct a MNP in the deep tissues of a human, 
versus the superficial location of a small mammal[45, 46].  One way to circumvent this 
issue is to create high gradient fields at the location for targeting.  Forbes, et al. examined 
the targeting of magnetic nanoparticles to magnetic implants[45, 47-49].  By placing the 
magnetizable magnetic implant into a uniform magnetic field, it was able to increase the 
gradient of the magnetic force used to capture magnetic nanoparticles in flow.  Similar 
work was done utilizing magnetically loaded cells captured with a magnetizable stent[50].   
Overall, much of the work-completed shows that magnetically targeted drug 
delivery is a promising option that still has a few hurdles to overcome.  Little research 
has been done on how magnetic nanoparticles can exit the vasculature of tumors and 
enter into the actual tumor tissues.  Similarly, research is still needed to determine 
whether or not these magnetic nanoparticles can be manipulated to move through soft 
tissues in order to evenly distribute the therapeutic agent that they are delivering. 
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1.4 Magnetic Nanoparticle Motion 
Most research published on magnetic nanoparticle motion investigates how 
magnetic nanoparticles flow through blood vessels and the magnetic forces necessary to 
remove particles from flow and attach them to either the vessel membrane or the 
magnetic implant [46, 51].  These published works are frequently mathematical models 
of the forces necessary to successfully quantify the magnetic field necessary to move this 
technology from in-vivo works on small animals to clinical trials. 
In vitro studies on magnetic nanoparticles motion through cell culture layers or 
soft tissues are minimal, yet studies analyze model tissues such as alginate[52] , type 1 
collagen[53] or agarose [54] to show that magnetic nanoparticles can in fact move 
through viscous materials.  These studies determined that movements of MNPs in model 
tissues are dependent upon size, magnetic field and surface properties.   
There have been few in vivo works on currently clinically feasible applications of 
magnetic nanoparticle movement through tissues, due to the high magnetic fields 
necessary to move MNPs through deeply set tissues in the human body.  The only in-vivo 
works that can be potentially clinically relevant in the near future examining MNP 
movement through soft tissues is being done on MNP movement within the eyes and 
ears[44, 55, 56].  These works are more clinically relevant, because of the superficial 
nature of the necessary targeting, allowing easy transferability into a clinical setting. 
In general, there are many questions that still need to be resolved about how 
magnetic nanoparticles move through tissues. The complex nature of the in vivo 
environment, as a result of interstitial pressures, blood flow, and potential uptake or 
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attachment of MNPs to non-targeted cell makes MNP movement characterization 
difficult.  To break down some of the complexities, more modeling and in vitro work, 
like that done by Barnes et al. is necessary in order to more fully reveal how MNPs move 
through tissues and cells [57]. 
1.5 Magnetic Nanoparticle Endothelial Cell Uptake 
Cells take up external materials by a process called endocytosis.  There are many 
different types of endocytosis but most can be placed into one of two main categories: 
clathrin-mediated or clathrin-independent endocytosis.  Clathrin-mediated endocytosis is 
characterized by the formation of morphologically distinct clathrin-coated vesicles on the 
cytoplasmic side of the membrane[58, 59]. Clatherin-independent forms of endocytosis 
are phagocytosis, pinocytosis and caveolae-mediated endocytosis.  Phagocytosis is a form 
of “cell eating” while pinocytosis is a form of “cell drinking”.  Phagocytosis describes 
particle uptake by cells.  It requires, and is initiated by, the attachment of the particle to 
the cell surface.  Pinocytosis, however, is the uptake of a soluble or colloidal substance, 
and unlike phagocytosis is an ongoing process that is not typically susceptible to 
stimulation[60].  Caveolae-mediated endocytosis is characterized by the presence of 
caveolae, which are plasma membrane invaginations enriched with cholesterol and 
sphingolipids[59]. 
Typically nanoparticles and other materials get into contact with cells via 
Brownian motion, and that contact with the cell membrane initiates an endocytotic 
pathway.  This process can be slow if there is a low concentration of low mass particles, 
however, magnetic nanoparticles exposed to a magnetic field cause a much faster initial 
introduction to the cell membrane[61].  While magnetic nanoparticles have proven to 
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increase gene transfection into a cell as a result of increased vector uptake, whether that 
uptake is the result of a faster introduction of uptake material to cells[62, 63] or a result 
of the magnetic force on the cells[64, 65] is greatly debated.   
The main characteristic that determines which endocytotic mechanism a cell uses 
in uptake is particle size [66-69].   Clathrin-mediated endocytosis has been found to be 
the standard uptake mechanism for particles below 200 nm[68].  Whereas, caveolae-
mediated endocytosis has been found to be the standard uptake mechanism for particles 
below 500 nm.  Therefore, size differences do not automatically give the endocytotic 
mechanism, as shown in previous work that shows that 200nm nanoparticles were 
uptaken into the cell by both clathrin-mediated and the clatherin-independent caveolae-
mediated endocytosis[62, 68].  
In order to test the type of endocytosis that is being utilized by the cell for particle 
uptake, pharmacological inhibitors are often used.  Common pharmacologic inhibitors of 
clathrin-mediated endocytosis are hypertoic sucrose, potassium depletion, cytosolic 
acidification, chlorpromazine, monodansylcadaverine and phenylarsine oxide.  However, 
none of these chemical maneuvers selectively inhibit internalization via clathrin-coated 
pits with absolute selectivity.  In particular, these inhibitors block uptake of fluid-phase 
markers and therefore cannot be used to decipher between clathrin-mediated endocytosis 
and macropinocytosis[59].  Inhibitors of caveolae-mediated endocytosis are statins, 
methyl-β-cyclodextrin, filipin and cholesterol oxidase[70, 71].  Again, use of these 
methods to block caveolae-mediated endocytosis also run the risk of damaging 
membrane integrity and therefore giving different uptake results[59].  Inhibitors of 
macropinocytosis and phagocytosis are sodium-proton exchange inhibitors such as 
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amiloride, f-actin depolymerizing drugs such as cytochalasin-D and inhibitors of 
phosphoinositide metabolism, such as PI3K[59, 71-73].  These inhibitors can potentially 
alter standard cell function so much that standard cellular endocytotic functions are 
altered.  Overall to date, there are no popular inhibitors of different endocytotic pathways 
that possess certain specificity to the pathway of interest.  However, these tools, in 
conjunction with other methodologies can help to shed light on cellular uptake 
mechanisms. 
Another characteristic that determines whether or not magnetic nanoparticles are 
effectively endocytosed into a cell is the MNPs surface properties[74].  It has been shown 
that nanoparticles with higher (less negative) zeta potentials show greater uptake than 
those with lower (more negative) zeta potentials[72, 75-77].  Different polymer coatings 
can alter the surface charge of MNPs. 
Lastly, it is important to note that the type of endocytosis of magnetic 
nanoparticles may vary from one cell type to another, despite there being no change in 
MNP surface properties or size.  The different endocytosis mechanisms, lead to different 
MNP intracellular storage compartments. Therefore it is important to examine MNP 
uptake on the particular cell type you are looking to target before choosing the size, shape 
and surface properties of the synthesized nanoparticles. 
1.6 Magnetic Nanoparticle Toxicity Mechanisms 
Magnetic nanoparticles have been shown to have unique toxic effects on cells as a 
result of actin cytoskeletal disruption, mitochondrial damage, DNA damage and oxidative 
stress [21, 78-80].  Oddly enough, it has been shown that smaller nanoparticles, less than 
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100 nm exhibit stronger toxic effects than larger nanoparticles, up to one micron[81, 82] .  
This study focuses on the affects nanoparticles have on cytoskeletal disruption as well as 
mitochondrial toxicity. 
1.6.1 Nanoparticle Induced Actin Cytoskeletal Disruption 
Endocytosed magnetic nanoparticles are located within the cytoplasm of a cell, 
therefore their presence, especially in large concentrations, could potentially disrupt the 
cytoskeletal organization[83].  The cytoskeleton is responsible for maintaining cell shape, 
protecting the cell, enabling cellular motion and its roles in intracellular transport and cell 
devision[84].  The cells contain three main kinds of cytoskeletal filaments, namely 
microfilaments (actin filaments), intermediate filaments, and microtubules.  The actin 
filaments are located beneath the cell membrane and are in charge of resisting tension and 
maintaining cell shape, participating in cell to cell or cell to matrix junctions and for 
forming cytoplasmic protuberances.  Investigating any changes in actin filaments as a 
result of magnetic nanoparticle endocytosis is important since they are responsible for so 
many of the cells life functions. 
There is minimal research regarding how magnetic nanoparticle incorporation 
into cells affects cytoskeletal organization and function. Wu et al. determined by imaging 
that cytoskeletal structures of human umbilical vascular endothelial cells (HUVECs) after 
loading with 35 nm iron oxide nanoparticles were greatly disrupted, as indicated by 
diminished vinculin spots and disorganized actin fibers and tubulin networks [85].  
Similarly, their ability to form a vascular network, migrate and invade was inhibited 
significantly.  Gupta et al., found that 15 nm PEG coated magnetic nanoparticles were 
less cytotoxic to the cytoskeletal organization and cell adhesion in comparison to non-
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coated magnetic nanoparticles of the same type [86]. They showed that microfilaments 
were well organized in thick bundles with stress fibers, while loaded cells with non-
coated nanoparticles had actin fibers that were less defined and visibly disorganized.  
Soenen et al., also saw that intracellular small iron oxide nanoparticles diminished cell 
proliferation, actin cytoskeletal organization as well as focal adhesion formation[87]. 
Most of the work that has been completed on cytoskeletal organization and 
function as a result of MNP uptake is on MNPs less than 100 nm in diameter.  Given that 
it has been shown that particles of this size have more detrimental affects in comparison 
to larger particles, it is necessary to determine whether the uptake of larger sized 
nanoparticles exhibit the same effects.  It is also important to note that it is sometimes 
difficult to see cytoskeletal organization defects and therefore cytoskeletal function may 
detect damage earlier than can be seen with imaging methods.  
1.6.2 Nanoparticle Induced Mitochondrial Depolarization 
Mitochondrial health is a strong indicator of cell health and potential apoptosis.  
DNA damage, ischemia and oxidative stress are all examples of apoptotic signals that 
lead to cell death through mitochondrial pathways[88].  The mitochondrial pathway of 
apoptosis begins with the permeabilization of the mitochondrial membrane[89]. 
Xia et al, has shown that 60nm magnetic nanoparticle inclusion into five different 
cell types, macrophages, epithelial, endothelial, hepatocyte  and pheochromocytomas 
showed toxicity at high loadings, but only a decrease in mitochondrial membrane 
potential, which indicates declining mitochondrial health, in macrophages and epithelial 
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cells[90].  Similarly, they showed that 200 nm MNP inclusions did not show any negative 
effects to the mitochondria. 
The decline in mitochondrial membrane potential as a result of magnetic 
nanoparticle loading can be related to research that shows increase in reactive oxygen 
species (ROS) production by cells who have endocytosed magnetic nanoparticles[91-93].  
Excess generation of ROS induces mitochondria membrane permeability, leading to a 
decline in membrane potential, triggering the apoptotic process[94, 95].  
 
1.7 Organization of Dissertation 
The aim of this thesis is to demonstrate that magnetic nanoparticles can be 
manipulated for potential drug delivery applications.  We show this by moving magnetic 
nanoparticles through viscous gels with an applied AC magnetic field, showing a force 
dependent uptake of magnetic nanoparticles in endothelial cells and lastly demonstrating 
that particle loaded cells can be manipulated to migrate through a membrane at a higher 
rate than that of control cells.  The thesis is organized into five chapters, 
• Chapter 1 – The introduction chapter, covers the background of nanoparticles and 
superparamagnetic nanoparticles. Investigates the benefits of superparamagnetic 
nanoparticles as well as their application and relevance in clinical applications, in 
particular MRI, hyperthermia, tissue engineering, cell separation and drug/gene 
delivery.  Lastly, it identifies work similar to ours such as magnetic nanoparticle 
manipulation, uptake and toxicity. 
• Chapter 2 – Chapter two examines magnetic nanoparticle synthesis, 
characterization and movement through viscous gels.  It shows a new magnetic 
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field set up that provides at alternating current magnetic field perpendicular to the 
static magnetic field and shows how this set-up increases the velocity of magnetic 
nanoparticle movement. 
• Chapter 3 – Chapter three investigates the mechanism of uptake, in particular the 
role of the magnetic field in endocytotic uptake, as well as preliminary cell 
viability assays and quantifies the magnetic nanoparticles entrapped into a cell 
after uptake under the influence of a magnetic field. 
• Chapter 4 – Chapter four studies more in depth the cell health of highly loaded 
endothelial cells by examining mitochondrial cell health and cytoskeletal 
arrangement, including confocal images.  It also includes a feasibility study on 
using magnetically loaded cells as potential vectors for targeted drug delivery 
through tissues. 
• Chapter 5 – Chapter 5 concludes the dissertation with a summary of the key 
findings and suggestions for future work. 
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Chapter 2: Time-varied magnetic field enhances transport of magnetic 
nanoparticles in viscous gel 
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2.1 Background   
Magnetic nanoparticles (MNPs) are being extensively investigated in biomedicine as 
evidenced by the exponential growth in the number of publications dealing with these 
systems. In biotechnology the main applications of the MNPs are related to separation, 
detection and processing of bio-molecules. Their importance in medicine currently relates 
to their applications as imaging contrast agents in Magnetic Resonance Imaging (MRI) 
[96]. One of the most promising, yet clinically unrealized applications of MNPs in 
medicine is targeted delivery of various therapies to designated locations in the body[97]. 
These therapies may include hyperthermia in which the magnetic particles are selectively 
heated by application of a high frequency magnetic field, e.g. in thermal 
ablation/hyperthermia of tumors [30, 98], ionizing radiation [99, 100], and targeted 
delivery of specific drugs  [101-107], gene vectors [63, 108-111], and cells [112-114]. 
The importance of targeted therapies stems from: (i) the reduction of the total quantity of 
drug or other therapeutic agent needed to attain a particular concentration in the vicinity 
of the target; and (ii) the reduction of the drug concentration at non-targeted sites [97, 
115] minimizing severe side effects.  
It has long been suggested that MNP targeting can be achieved through the use of 
magnetic field gradients, which apply a force on the magnetically responsive carriers and 
cause them to move to targeted locations. However, there are still serious gaps in our 
understanding of the mechanisms of MNP transport through soft tissues in a human body. 
Our lab and others have recently demonstrated the feasibility of the magnetic targeting 
approach through the vascular system, where MNPs or magnetically labeled cells were 
successfully localized to cardiovascular stents under static or flow conditions [46, 49, 114, 
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116]. The concept of using oscillating and static magnetic fields to enhance non-viral 
gene transfer in vitro has also been reported [16, 117]. Although these results are 
promising, MNPs often need to be transported not just through the circulatory system, or 
across cell membranes, but across blood vessel walls, the blood brain barrier or through 
other soft tissues. Forced transport of MNPs through soft tissues remains poorly 
understood [53, 57, 118-121]. Magnetic beads have been employed in rheological and 
magnetic actuation studies of cells following original investigations by Francis Crick, but 
these studies are not focused on active (external force controlled) transport of particles in 
tissues and cells [122, 123].  
 In the context of MNP transport, soft tissue is a multifaceted material that is more 
complex than blood, one of the most complex fluids,. Under the action of an external 
field gradient, MNPs will move through a viscous fluid at a constant rate dependent upon 
the fluid viscosity. However, in soft tissue, the MNPs reside in a complex material 
structure composed of liquids and solids.  This material may exhibit a non-zero yield 
stress (the external stress below which the material responds elastically and above which 
it may respond as a viscous material) such that the MNPs may not move at all if the 
external magnetic force does not exceed a certain minimal value. The yield stress and 
viscous drag may depend strongly on the rate of variation of the magnetic forces and on 
MNPs characteristics, e.g., size, shape, degree of magnetic loading and surface properties. 
The mechanism of MNP transport across blood vessel walls and through soft tissue may 
vary depending on these characteristics. In order to successfully manipulate MNPs 
through soft tissues, it is important to determine the characteristics of the applied 
magnetic forces that produce the most controllable transport of the particles. The main 
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goal of the present study was to investigate the effect of a time-varying magnetic field 
superimposed with the static field gradient on MNPs mobility in viscous gel. 
Understanding these effects will enable development of means by which transport of 
MNPs through soft tissue can be controlled to a significant extent in a number of 
therapeutic approaches.  
2.2 Materials and Methods 
2.2.1 Materials 
Poly(D,L-lactide) (average Mw: 75,000–120,000), ferric chloride hexahydrate, 
ferrous chloride tetrahydrate, sodium hydroxide, oleic acid, and polyvinyl alcohol (87-
90% hydrolyzed, average Mw: 30,000-70,000) were obtained from Sigma-Aldrich (St. 
Louis, MO, USA). All solvents were purchased from Fisher Scientific (Pittsburgh, PA, 
USA) and were of HPLC grade. Deionized water used in all experimental procedures was 
obtained using a Milli-Q water purification system (Millipore, Bedford MA, USA). The 
viscous gel, Surgilube (15,000 cp) was obtained from (Altana Inc. NY, USA).     
2.2.2 Magnetic Nanoparticle Formulation 
Magnetite was obtained from ferric and ferrous chloride by alkaline precipitation 
as previously described elsewhere [108, 114, 124, 125]. In this study we investigated a 
novel aspect of nanoparticle formulation, the magnetite loading. Particularly we studied 
the effect of various magnetite loadings on MNP formation, magnetic properties and 
transport. For this purpose, various amounts of lipophilic magnetite were dispersed in 6 
ml of chloroform, forming stable magnetic fluids further used for nanoparticle 
preparation. The amounts of iron salts and oleic acid used to obtain various loadings are 
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described in Table 2.1. Polylactide (PLA)-based magnetite-loaded nanoparticles (MNPs) 
were prepared by the emulsification-solvent evaporation method [11, 108, 114]. 
Typically, 200 mg of PLA was dissolved in 6 ml of magnetic fluid (containing various 
amounts of magnetite) to form an organic phase. The organic phase was emulsified in 15 
ml of pre-chilled 1.5% (w/v) polyvinyl alcohol (PVA) by sonication, and the organic 
solvents were removed by evaporation under reduced pressure at 30°C. The particles 
obtained were passed through a 1.0 mm glass fiber prefilter (Millipore, Bredford, MA 
USA), dialyzed against 4 L of water with several water replacements for 24 h using a 
dialysis membrane with a 300,000 Da cut-off (Spectrum Laboratories, Inc., Rancho 
Dominguez, CA, USA) to remove unbound PVA, and lyophilized with 10% (w/v) 
trechalose as a cryoprotectant. Lyophilized MNPs were kept at +4°C and resuspended in 
deionized water before use.  
Table 2.1. Amounts of the reagents used to obtain iron oxide loadings in a range of 10-
50% (w/w).  
 
2.2.3 MNP characterization 
Particle size and zeta-potential measurements were performed using a Particle 
Size Analyzer (Zetasizer Nano-ZS90, Malvern, UK). The magnetic properties of MNPs 
were obtained from the hysteresis curves of 5 ml samples (corresponding to 125 mg) air-
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dried on 4 mm diameter round coverglass slides measured by alternating gradient 
magnetometer (Princeton Instruments Corporation, Princeton, NJ, USA). The iron 
content of MNPs was determined spectrophotometrically (using Synergy 4 multimode 
plate reader, Biotek, USA) in 1 N hydrochloric acid (l=335 nm) against a standard curve 
after MNPs degradation with 1N aqueous sodium hydroxide (90°C, 30 min) and 
dissolution of the iron containing precipitate in the acid solution [108]. Transmission 
electron microscopy of MNPs samples was performed using JEM-1230 electron 
microscope (JEOL ltd, Japan). The samples of MNPs were diluted 1:10 with DI water 
and deposited on carbon-coated grids (Electron Microscopy Sciences, USA) with no use 
of contrast staining.   
2.2.4 MNP velocity experiments 
MNP velocity experiments were conducted in a translucent gel (15,000 cp) with 
uniform texture, free of bubbles and inclusions. This gel has been chosen as a 
commercially available material with a viscous texture that we could use as a feasibility 
study and a simplistic model to demonstrate the effects of various conditions on MNP 
transport through a viscous fluid. The gel was injected into a section of a disposable 
plastic pipette (4 mm in diameter and 10 mm in length) that served as a channel for the 
transport studies. A 3 ml aliquot of MNPs was placed into one end of the channel and 
allowed to settle on the gel’s surface. The other end of the channel was placed flush 
against the permanent magnet such that the MNPs were located 10 mm away from the 
magnet.  The distance that the MNPs traveled toward the magnet was measured in three 
minute intervals, by tracking the leading edge of the moving particles, and converted into 
MNPs velocities (mm/sec). The leading edge was tracked visually by using a magnifying 
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lens and a micro-ruler with 0.1 mm divisions. Given the assumption that error is ½ of the 
minor scale, the error associated with these readings would be 0.05mm. The experimental 
magnetic set up is shown in Figure 2.1.  
 
 
Figure 2.1.  The experimental magnetic setup consisting of an AC field generator, a 
permanent NdFeB magnet and the transport channel positioned between cores of 
electromagnet and the permanent magnet.  
 
To determine the AC field parameters that resulted in maximal increase in the 
MNPs velocity through the viscous gel, a series of optimization experiments using 
various AC field settings and frequencies were performed. In these experiments MNPs 
loaded with 30% (w/w) magnetite were used.  The voltages on the AC power supply were 
set at 0.2-2.7 V. For each voltage, the frequency was tested at 50 and 100 Hz. The RMS 
(root-mean-square) AC field values were then measured for each voltage and frequency 
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using a hand-held Lakeshore 410 magnetometer (Lake Shore Cryotronics, Inc.). The 
velocity of the MNPs at each AC field setting was calculated, and the AC field that 
resulted in the maximal MNP velocities was used in subsequent magnetic transport 
efficiency experiments.   
2.2.5 Magnetic Transport Efficiency 
Static and AC field experiments (n=5) were conducted for each magnetite loading 
between 20-50% (w/w) using a 10 mm long channel (as described above).  At the 
completion of the exposure time (30 min), the 2 mm of the channel closest to the 
permanent magnet was sliced off to separate the fraction of MNPs that completed motion 
from those that did not travel to completion (i.e., remained in the 8 mm segment).  Since 
the MNPs do not move in a large clump but rather as a leading edge with a tail, in order 
for the tail to reach the completion point the leading edge would have had to leave the 
experimental channel.  Therefore, we decided to collect the final 2 mm of motion to 
quantify the mean fraction of particles that were moving. Both segments of the channel 
were dried in a Petri dish for 24 hours.  Then, the dry residues of gel samples containing 
the MNPs were transferred to Eppendorf tubes. The samples were re-suspended to a 
liquid form with 20 mL of DI water. Then the MNP-containing samples were incubated 
with 1M NaOH to digest PLA and release the magnetite (90oC, 30 min). The released 
magnetite was separated by centrifugation and dissolved in 1M HCl (90oC, 1hour). The 
amount of iron in both channel segments was determined spectrophotometrically (l=335 
nm). The resulting value allowed us to estimate the fraction of particles based on their 
known composition.  An initial reading was made of the iron content by analyzing the 
absorption at 335nm of total iron from a 3 ml sample of MNPs in order to normalize the 
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absorption readings of the MNPs that completed motion and those that did not.  The 
fraction of MNPs that completed motion (originated from the 2 mm segment of the 
channel closest to the NdFeB permanent magnet) is presented as a percentage by 
comparing the MNPs that completed motion to that of the total initial MNPs dose.  
2.2.6 Statistical analysis 
Experimental data in plots were presented as means ± SD.  The evaluation of 
which magnetic fields to use against the control (static field) was analyzed using 
Dunnett’s test.  A one-tailed, unequal variances t-test was then used to analyze the 
significance (P<0.05) of the velocities between the resulting experimental magnetic 
setups with varying AC frequencies.  
2.3. Results  
2.3.1 MNPs formulation and characteristics 
Magnetic PLA-based nanoparticles were formulated by varying the inclusion of 
the magnetite within the PLA matrix in a range of 10 to 50% (w/w).  Non-magnetic NPs 
were prepared as a control formulation. Various magnetite loadings did not cause any 
adverse effects on the stability of the emulsions or the formation of MNPs following the 
evaporation step. Stable oil-in-water emulsions were obtained for all formulations. 
During the evaporation step, no visible precipitates were observed. This evidence 
correlated well with the high magnetite entrapment yield that was estimated to be about 
95% for all formulations. The MNPs hydrodynamic diameters ranged between 213 to 275 
nm for different magnetite loadings averaging at 239±23 nm (by the dynamic light 
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scattering). No correlation was observed between the magnetite loading and MNPs size 
distribution (Table 2.2).  
Table 2.2 Magnetic entrapment yield, size and surface charge characterization of MNPs. 
 
The MNPs size obtained by the Transmission Electron Microscopy (TEM) was in 
agreement with the light scattering data (Figure 2.2). Zeta potentials indicating the MNPs 
surface charge were slightly negative and varied between -5.75 and -9.27 mV (Table 2.2).  
The resulting PVA-stabilized PLA-based magnetic nanoparticles of various magnetite 
loadings (10-50% (w/w)) exhibited a dose-dependent superparamagnetic behavior 
showing no significant hysteresis (Figure 2.3). The magnetic moment dependence on the 
magnetic field was nearly linear up to 1 kOe, reaching 65-70% of the saturation 
magnetization value for all magnetic formulations, whereas a comparatively low 
increment in magnetization was observed on further increasing the field to 5 kOe. The 
average normalized values of MNP magnetizations calculated at 1.0 and 5.0 kOe 
(saturation magnetization) were found to be 35±1 and 50±1 (emu/g) respectively.  
Formulation 
description 
Magnetic 
entrapment yield, 
% 
Iron oxide loading, 
% (w/w) 
Size, nm Zeta potential, 
mV 
0% iron oxide TL* - - 231 -5.75 
10% iron oxide TL 94.1±1.8 9.7±1.0 244 -6.80 
20% iron oxide TL 96.7±3.8 19.9±0.7 253 -5.70 
30% iron oxide TL 94.9±8.6 29.3±2.3 213 -6.95 
40% iron oxide TL 96.9±1.3 39.6±0.6 275 -7.43 
50% iron oxide TL 94.6±0.6 48.8±0.4 219 -9.27 
*TL=Theoretical Loading. 
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Figure 2.2. Transmission electron microscopy of (A) iron oxide crystals stabilized with 
oleic acid, (B) 20% and (C) 50% (w/w) iron oxide loaded polylactic (PLA)-based 
magnetic nanoparticles prepared by the emulsification-solvent evaporation method. The 
samples of MNPs were deposited on carbon grids and after drying visualized 
immediately without contrast staining.  
Figure 2.3. Magnetization curves of MNP formulations loaded with 10-50% (w/w) of 
iron oxide. Note the absence of remanence (superparamagnetism) exhibited by all MNP 
formulations. There is a linear correlation between the iron oxide content and the 
saturation magnetization values.  
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2.3.2 Generation of static and AC magnetic forces 
To understand how magnetic forces are generated, it is important to know the 
dependence of the magnetic moments of PLA nanoparticles loaded with magnetite on the 
external magnetic field. The shape of the magnetization curve approximates the well-
known Langevin function that can be derived theoretically for non-interacting 
superparamagnetic nanoparticles, which fill the core of the PLA polymeric sphere. The 
Langevin function is given by ηηη
1coth)( −=L , where kT
BM s=η   and sM , k, T and 
B are particle’s saturation magnetic moment, Boltzmann constant, absolute temperature 
and magnetic flux density, respectively. It is worth noting that for small values of the 
external magnetic flux density B, when 1<<= kT
BM sη , the Langevin function can be 
well approximated as a linear function of the field. However, when 1>= kT
BM sη , the 
Langevin function begins an asymptotic approach to 1. This region of the magnetization 
characteristic is known as saturation.  
 The magnetic force on spherical particles is usually derived by treating them as 
magnetic point dipoles and is given by:  
( )BMF  ∇⋅=                                                                    (1) 
where ACstatic MMM

+=  is the particle’s magnetic moment and ACstatic BBB

+= is the 
total magnetic field applied. The magnetic field generating set-up employed in these 
experiments and positioning of the sample within it are presented in Figure 1. We have 
chosen to employ a configuration where the static field at the location of the sample is 
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mostly perpendicular to the AC field produced by the electromagnet with laminated core 
(the laminated core is needed in order to minimize eddy current screening of the AC 
field). The static field generated by the permanent magnet (NdFeB) varies significantly 
along the magnet’s and the sample axis (z-axis), creating fairly strong field gradients. The 
average z-field component at the sample location was measured to be around 3.0≈staticzB
Tesla (3 kOe), while z-field gradient along the z-direction was measured to be around 
10≈
∂
∂
z
Bstat icz Tesla/m. The location of the average z-field and gradient is presented in 
terms of the MNPs at their furthest distance from the magnet (10 mm), therefore the 
starting point.  This then gives the lowest gradient field that they will experience 
throughout their period of motion. The gradient 
x
Bstaticx
∂
∂  of the static field component 
directed across the electromagnet gap (x-axis) was somewhat larger (around 15 Tesla/m) 
along the direction of this field component (x-direction). It was observed that gradient of 
the z- field along its axis is far greater than its gradients 
x
Bstaticz
∂
∂  and 
y
Bstaticz
∂
∂  
perpendicular to the z-axis. At the average value of the axial static field observed in these 
experiments, the particles’ magnetic moments were nearly saturated (see Figure 3). Using 
the observations described above, the static magnetic force on the PLA nanoparticles can 
be obtained from (1) and is approximately given by: 
z
BMF
static
z
s
static
z ∂
∂
≈                                                        (2) 
Using the equation (2) the magnetic force in z-direction acting on particles located at the 
starting point of motion (10 mm away from the permanent magnet) was estimated to be 
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about 3fN. The AC force on the PLA nanoparticles arises mainly due to the AC 
component of the magnetic moment and due to the static field gradient (gradient of the 
AC field is confirmed to be much smaller than the static field gradient in our set-up). The 
strongest component of the AC force, therefore, in our set-up, is the one along the 
electromagnet gap (x-axis). This force is approximately given by: 
x
B
B
BMF
static
x
static
z
AC
x
s
AC
x ∂
∂
=                                                      (3) 
Taking into account that gradients 
z
Bstaticz
∂
∂  and 
x
Bstaticx
∂
∂  are about the same in magnitude, 
it becomes clear that the ratio of AC to static force magnitudes scales as 
static
z
AC
x
B
B . In our 
experiments this ratio was on the order of 0.01. Thus, the AC force employed in the 
preliminary experiments is estimated to be about 100 times weaker than the static force 
applied to the PLA nanoparticles and estimated as 0.03 fN. This analysis remains fairly 
accurate at relatively low frequencies (below about 100 kHz) where the magnetic 
moments can be assumed to respond nearly instantaneously to the external field.   
2.3.3 Variations of AC magnetic field 
Figure 2.4 shows the velocities of 30% (w/w) magnetic loading MNPs at various 
AC field values tested at 50 and 100 Hz frequencies, superimposed with the static field 
generated only by the permanent NdFeB magnet. The application of an AC field 
increases the velocity of the MNPs in viscous gel substantially as compared to the 
presence of a static field only. Under “no magnetic field” control condition the particles 
remain suspended in the initial deposition point showing no movement for at least 12 
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hours. Dunnett’s test showed that with the exception of the lowest voltage at 100 Hz, all 
AC magnetic fields significantly increased the velocity of the MNPs (P<0.05).  T-test 
comparisons between varying AC frequencies within experimental groups with the same 
power supply voltage showed no statistical differences.  Therefore, further experiments 
were conducted using a RMS AC value of 16.4 Oe at a frequency of 50 Hz, as MNPs 
experienced the highest velocity under these conditions and the field requirements fit well 
within the range of our power supply.   
 
 
Figure 2.4. The velocities of 30% (w/w) MNPs at various AC field values tested at 50 
and 100 Hz frequencies, superimposed with the static field generated only by the 
permanent magnet (n=3).  All AC conditions were significantly different than static 
(P<0.05). All AC fields were statistically different from the static fields (p<0.05). 
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2.3.4 MNPs velocity as function of the magnetite loading and the MNPs 
transport efficiency 
The transport of MNPs loaded with 20-50% (w/w) magnetite was compared at 
static field conditions versus static field superimposed with an AC field (termed later as 
an AC field condition for simplicity). The MNP transport efficiency is defined as a 
fraction of the MNPs that reached the 2 mm of the channel closest to the permanent 
magnet during 30 min. The transport of MNPs loaded with 20% (w/w) magnetite was 
very poor (<10% efficiency) and did not significantly differ between the static and an AC 
field conditions (Figure 2.5). At 30% (w/w) magnetite loading, the efficiency with an 
added AC field increased sharply to 60%, while the static remained unchanged.  At 40% 
and 50% (w/w) magnetite loading, the magnetic transport efficiency with the AC field 
reached a plateau at 80%.  The maximal enhancement of the magnetic transport 
efficiency (AC vs. static) is nearly 30-fold at 30% (w/w).  At 40% and 50% (w/w) 
magnetite loading, the enhancement in magnetic transport efficiency by the AC field is 
less pronounced, yet the differences are statistically significant with P<0.05.  
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Figure 2.5. MNP transport efficiency as function of different magnetic field settings 
(static vs. AC) and iron oxide loadings, n=3.  The AC field points are statistically 
different than the corresponding static points with p<0.05. 
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Figure 2.6. MNP velocity as function of iron oxide loading. An AC field was generated at 
RMS value of 16.4 Oe and frequency of 50 Hz, n=3. The static and AC fields combined 
yielded MNP velocities that were statistically different from their static field only 
counterparts (p<0.05). 
 
To further examine the motion of particles and demonstrate the effect of the 
magnetite loading on the MNPs mobility, we measured the velocity of the MNPs loaded 
with 10-50% (w/w) magnetite at AC and static field conditions. Theoretically, MNPs 
loading should increase both the static and the AC forces equally. In these experiments an 
AC field was generated at RMS value of 16.4 Oe and a frequency of 50 Hz.  The change 
in MNP displacement was recorded at 3-minute intervals, and the velocity of the particles 
was calculated.  For all formulations, the velocity with the AC field was greater than with 
static field alone.  A linear increment in the magnetite loading within MNPs resulted in a 
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linear increase in MNP velocity through the viscous gel as shown in Figure 2.6 for both 
AC and static fields; however, the slopes of the curves at both field conditions were 
significantly different (P = 0.03). Both fit lines had a small but nonzero x-intercept, 
indicating the magnetite content below which no motion would occur. 
2.4. Discussion 
2.4.1 MNPs formulation and characterizations 
 The initial aim of this research was to formulate a family of superparamagnetic 
nanoparticles loaded with various amounts of the iron oxide (magnetite) and evaluate the 
effects of various magnetite loadings on stability of the oil-in-water emulsions, MNPs 
size distribution and MNPs surface charge. The magnetite crystals obtained by alkaline 
precipitation [108, 124, 125] are not uniform and ranges between 5 to 20 nm (Figure 2.2 
A). Coating the magnetite crystals with oleic acid provides steric stabilization and allows 
dispersion of the lipophilic magnetite in non-polar solvents (chloroform in this study). 
We formulated MNPs using an emulsification solvent evaporation method [11]. In this 
technique, the organic phase containing the polymer and the lipophilic magnetite (coated 
with oleic acid) is emulsified with an aqueous phase containing emulsion stabilizer to 
obtain stable oil-in-water (o/w) emulsion and the polymeric nanoparticles are formed 
after solvent evaporation [97]. The poly(lactic acid), PLA was chosen as a biodegradable 
and biocompatible  polymer [126-129] to form stable solid-phase magnetic nanoparticles 
to be used in transport studies. Poly(vinyl alcohol), PVA has been preferentially used as 
colloidal stabilizer in many studies. PVA has been shown to be an excellent stabilizer to 
prepare biodegradable non-magnetic and magnetic nanoparticles using a variety of 
techniques [11, 130]. Furthermore it is one of the few stabilizers that prevents 
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nanoparticle aggregation during post-preparative steps (e.g., purification and freeze 
drying), enhancing the yield of dry nanoparticle product without addition of other 
adjuvants [11]. In our studies, stable oil-in-water emulsions were obtained for all 
magnetite loadings with 1.0 and 1.5% (w/v) PVA. The concentration of 1.5% (w/v) PVA 
was chosen to ensure the desired stability of the oil-in-water emulsions and therefore was 
further used in all final formulations. Due to its amphiphilic nature, PVA distributes only 
on the surface of PLA-based MNPs. The main organic component around the magnetite 
is PLA, while the fractions of oleic acid and PVA are minor relatively to the magnetite 
and PLA. The average size distribution of the PLA-based magnetic nanoparticles varied 
in 213-275 nm range (by the dynamic light scattering, Table 2.2). This result was in 
agreement with our TEM observations (MNPs average size 230-300 nm, Figure 2) and 
correlated well with the literature data reported for the non-magnetic nanoparticles 
stabilized with 0.5-2% PVA, homogenized by different techniques and obtained within a 
size range of 180-350 nm [11]. The inclusion of various amounts magnetite within the 
PLA matrix (up to 50% (w/w)) seemed to have no effect on the MNPs size (Table 2.2). 
However, MNPs exhibited magnetite dose-dependent superparamagnetic behavior 
(Figure 2.3). The nearly equivalent MNP size for the all magnetite loadings and increased 
magnetic responsiveness for particles of higher magnetite loadings suggest that the 
differences in magnetic responsiveness are due to different magnetite packing within the 
polymeric core. Indeed, our qualitative TEM data support this conclusion and show a 
denser packing of the magnetite crystals at 50% (w/w) comparing to 20% (w/w) loading 
(Figure 2.2 C and B). This observation also remarkably correlates with the 
experimentally quantified magnetite loadings as shown in the Table 2.2. Zeta potential, a 
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measure of surface charge, can influence particle stability, cellular uptake, intracellular 
trafficking as well as transport of MNPs through a complex media such as soft tissue. In 
some formulations, higher zeta-potential values, either positive or negative, are necessary 
to ensure colloidal stability and avoid aggregation of nanoparticles. However, the 
colloidal stability of nanoparticles can also be achieved by the sterric stabilization using 
non-charged polymers (PVA in this study). Zeta potential of studied formulations was 
slightly negative (in a range -5.75 to -9.27 mV, Table 2) and did not correlate with the 
magnetite loadings. Usually PLA has a certain amount of uncapped end carboxyl groups 
that result in a relatively high (above -30 mV) negative surface charge of the 
nanoparticles in neutral buffer [131]. However, when PLA nanoparticles are formulated 
with PVA as an emulsifier, the zeta potential becomes less negative (-6 to -10 mV) [132]. 
This occurs because PVA molecules are shielding the charged surface groups of PLA. 
The colloidal stabilization of MNPs in our case was mainly due to steric hindrances 
between PVA chains on the surface of neighboring MNPs rather than by charge due to 
low values of zeta potential of our formulations. Thus, MNPs formulated and used in this 
study can be seen as nearly neutral, colloidally stable particles that do not interact with 
themselves or with the viscous gel medium due to weak surface charges.  
2.4.2 MNP transport studies 
To evaluate the effect of an AC field on MNP transport we measured MNP 
average velocities at different AC and static field conditions. The addition of an AC field 
component significantly (P<0.05) increased velocity of the MNPs in viscous gel (Figure 
2.4). The MNP maximum velocity was reached at 50 Hz frequency in an AC field range 
of 16-22 Oe. We did not observe a clear effect of varying AC frequencies on MNPs 
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velocity; however, in the field range of 16-22 Oe the 50 Hz frequency demonstrated a 
quantitatively superior MNPs velocity increase, and therefore the field of 16.4 Oe at 50 
Hz was chosen as optimal. As a result all further MNP transport efficiency experiments 
were completed with the stated power supply settings. It is of note that initial experiments 
were conducted using frequencies in the range of 5-15 Hz.  However, these experiments 
yielded no statistical differences from static field.  Statistically different results from the 
static field were shown to be present at 50 Hz.  Therefore, given this knowledge the 
power supply used in our setup to produce 50Hz electromagnetic fields had a maximum 
frequency of 100Hz. In order to keep experiments consistent, they were conducted using 
the minimum frequency that showed results and the maximum frequency we could 
produce on our setup. An expansion of these frequencies to a broader range is necessary 
to better map the effect of AC field frequency with MNP movement.  
 The transport efficiency experiment tests the ability to move MNPs long distances 
within a clinically feasible time frame. For the same field strength and gradient, the lower 
magnetite MNPs move more slowly (Figure 2.6), and this limits the range over which 
they can be captured by the magnetic field within a reasonable time frame.  This is where 
the enhanced transport produced by the AC magnetic field component perpendicular to 
the direction of motion is most dramatically illustrated.  We have not only increased 
magnetic particle velocity but we have also increased the fraction of MNPs that travel to 
the final destination, as shown in the MNPs transport efficiency results (Figure 2.5).  The 
increase in MNPs transport efficiency varies according to the magnetite loading in the 
particles. MNPs loaded with 20% (w/w) magnetite show no difference in MNPs transport 
efficiency at both AC and static field conditions (Figure 2.5). MNPs with 30%, 40% and 
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50% (w/w) magnetite loadings experienced the statistically significant increase in 
transport efficiency with the addition of AC field component.   
In order to determine the mechanism resulted in the improved magnetic transport 
efficiency, the velocity of the MNPs with respect to magnetite loading was plotted for 
both static and AC conditions as shown on Figure 2.6.  These results show that an 
increased magnetite loading results in a higher velocity for both static and AC conditions, 
given the higher magnetic force obtained in the setup.  However, we can also note that 
the slope of the static only condition is lower than that of the AC condition.   
 Our results imply that the reason that the AC field is having an effect on the 
velocity of the MNPs is because of a decrease in the effective local viscosity of the 
viscous fluid around the particles.  The y-axis in Figure 2.6 shows the velocity of the 
particles which is related to the drag force on the MNPs.  Since our experiments dealt 
with small spherical particles moving slowly through a viscous fluid, resulting in a low 
Reynolds number, the drag force, Fd, for spherical particles moving slowly through a 
viscous fluid is given by Stokes’ Law: 
     rVFd πη6−=       (4) 
where, η is the fluid’s viscosity and r is the Stokes radius of the particle. According to the 
equation (1), the magnetic force on the particle is proportional to the particle’s magnetic 
moment and the gradient of the magnetic field applied.  The magnetic moment of 
particles depends linearly on the percent of the magnetite loading (Figure 2.3). Thus, the 
percentages of the magnetite loadings (presented on the x-axis in Figure 2.6) are 
proportional to the magnetic forces acting on the particle due to the applied field. At low 
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Reynolds number, the magnetic force will be balanced by the drag force, so the slope of 
the lines in Figure 6 can be interpreted as being inversely proportional to the apparent 
viscosity of the medium (since r is constant).  The increase in slope with the addition of 
the AC field can be explained by the magnetic forces resulting from the combination of 
static and AC field causing a decrease in localized gel properties immediately 
surrounding the particles. It is noteworthy to mention that possible AC field coupling to 
the particles resulting in an elevated temperature (magnetic fluid hyperthermia, MFH), 
which might enhance the diffusion of particles or lead to a gel’s phase transition is highly 
unlikely due to a completely different operational frequency range applied in MFH (0.1-
260 MHz) as compared to frequencies used in this studies [133-136]. While further 
investigation is needed to fully elucidate the mechanisms underlying the phenomena, it is 
believed that the oscillating AC magnetic field allows increased efficiency in particle 
movement because of localized shear thinning.   
2.5 Conclusions 
Biodegradable MNPs were formulated with variable loading of magnetite in a 
range of 10-50% (w/w). The inclusion of magnetite up to 50% (w/w) did not affect MNPs 
size distribution and surface properties. Magnetic susceptibility of the MNPs linearly 
correlated with the percentage of the magnetite loading. The application of an AC field 
significantly increased velocity of the MNPs in viscous gel reaching the maximum at a 
frequency of 50 Hz and AC field of 16-22 Oe as compared to a static field conditions. 
The results of this study show that the “oscillating” effect of an AC magnetic field greatly 
improves the ability to transport MNPs within soft media. While more investigation is 
needed to fully elucidate the mechanisms underlying the phenomena of the enhanced 
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MNPs transport, it appears that oscillating AC magnetic field reduces the effective 
viscous drag acting on carriers.  
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Chapter 3: Force dependent relationship for magnetically loading 
endothelial cells for targeted delivery 
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3.1 Background 
Many groups have analyzed the endocytotic mechanisms used for nanoparticles to 
enter cells and MNP entry into cells has long been demonstrated to increase gene 
transfection in cells.  However, MNP enhanced gene transfection papers identify the 
amount of transfection shown not the number of particles that are loading.  The objective 
of this study is to examine how a static magnetic field influences MNP uptake into 
endothelial cells and how to quantify the loading of MNPs.   
Whether for targeted drug delivery or tissue culture purposes, in order for movement 
of magnetically loaded cells to be most productive, it is best to load them with maximal 
amounts of magnetic nanoparticles, thereby increasing the magnetic responsiveness of 
the cell.  However, the high loading of MNPs cannot affect cellular function, if the 
purpose is to deliver live, functioning cells.  In this study we show that we can highly 
load endothelial cells without significantly impairing their function. 
3.2 Materials and Methods 
3.2.1 Materials 
Poly(D,L-lactide) (average Mw: 75–120 kD), ferric chloride hexahydrate, ferrous 
chloride tetrahydrate, sodium hydroxide, oleic acid, and polyvinyl alcohol (87-90% 
hydrolyzed, average Mw: 30-70 kD), N-Hydroxysuccinimide (NHS), N,N'-
Diisopropylcarbodiimide (DIC)  were obtained from Sigma-Aldrich (St. Louis, MO, 
USA). Poly(D,L-lactide) 100DL 4A (acid end, Mw: 54 kD, Mn: 34 kD) was obtained 
from Lakeshore Biomaterials (Birmingham AL, USA). BODYPY®TR (588/617), 
Live/Dead Viability Cytotoxicity staining kit and Cell-TraceTM Calcein Green were 
purchased from InvitrogenTM (Carlsbad, CA, USA). All solvents were obtained from 
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Fisher Scientific (Pittsburgh, PA, USA) and were of HPLC grade. Deionized water used 
in all experimental procedures was obtained using a Milli-Q water purification system.  
Glass fiber 1.0 µm and 5.0 µm syringe driven filters were purchased from Millipore 
(Millipore, Bedford MA, USA). Phosphate buffered solution (PBS) and Dulbecco’s 
modified eagle’s medium (DMEM) supplemented with L-Glutamine, 4.5g/L Glucose and 
Sodium Pyruvate was from MediaTech (Manassas VA, USA), BenchMarkTM heat 
inactivated fetal bovine serum (FBS) was obtained from Gemini Bio-Products (West 
Sacramento, CA USA), Alamar Blue was purchased from AbD Seroteck (Kidlington, 
UK). Fluoroblok transwell inserts with 8µm pores were purchased from VWR (Radnor, 
PA). The LifeSep neodymium magnet fit for cell culture plates was purchased from 
Dexter Magnetic Technologies (Elk Grove Village, IL, USA). Glass bottom cell culture 
dishes for confocal imaging were purchased from MatTek Corporation (Ashland, MA, 
USA).  For cholesterol depletion experiments and cytochalasin-D experiments, Methyl-
B-cyclodextran was obtained from Sigma-Aldrich (St. Louis, MO, USA) and the Amplex 
Red Cholesterol Assay kit was obtained from Invitrogen (San Diego, CA, USA). 
3.2.2 Magnetic Nanoparticle Synthesis  
Magnetite was obtained from ferric and ferrous chloride by alkaline precipitation 
as previously described [137]. In this study, we examined the effect of various magnetite 
loadings within (poly)lactic acid (PLA) matrix on cellular uptake of magnetic PLA-based 
nanoparticles. For this purpose, various amounts of lipophilic magnetite (28, 83 and 195 
mg) were dispersed in 6 ml of chloroform, forming stable magnetic fluids further used for 
magnetic nanoparticle preparation. The above amounts of magnetite are calculated based 
on the input amount of iron salts to result in 10%, 30% and 70% (w/w) theoretical 
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magnetite loadings [137]. In our earlier studies we found that the efficiency of 
encapsulation for 10% and 30% magnetite loading was ~95% [137, 138]and ~90% for 
70% loading (in this study). Polylactide (PLA)-based magnetite-loaded nanoparticles 
(MNPs) were prepared by the emulsification-solvent evaporation method as described 
elsewhere [137, 138].  Fluorescent PLA-based magnetic particles were formulated by 
dissolution of 180 mg of non-labeled PLA and 20 mg of fluoresecently labeled 
(BODYPY®TR (588/617) PLA in 6 ml of magnetic fluid (containing various amounts of 
magnetite) to form an organic phase. The organic phase was emulsified in 15 ml of pre-
chilled 1.5% (w/v) polyvinyl alcohol (PVA) by sonication, and the organic solvents were 
removed by evaporation under reduced pressure at 30°C. The particles obtained were 
passed through a 1.0 mm glass fiber and lyophilized with 10% (w/v) trechalose as a 
cryoprotectant.  Lyophilized MNPs were kept at +4°C in 100 µL aliquots and re-
suspended in deionized water before use.   
Fluorescently labeled magnetic nanoparticles were also synthesized.  Carboxyl 
end groups of PLA were coupled with amine-containing BODIPY® TR (588/617) 
cadaverine using carbodiimide chemistry in organic medium. The carboxyl group 
activation step was carried out in methylene chloride using NHS/DIC at a 1:1 molar ratio 
to obtain succinimidyl ester of PLA (PLA-Su). The ratio of NHS/DIC to PLA was kept 
around 300-fold of molar excess.  The activated PLA-Su was precipitated three times 
from methylene chloride into cold methanol. In the next step, the PLA-Su was coupled 
with BODIPY® TR (588/617) cadaverine under argon atmosphere for 24h at basic 
conditions in methylene chloride supplemented with triethylamine. The excess of base 
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was neutralized with acetic anhydride and the fluorescently labeled PLA was precipitated 
three times from methylene chloride into cold methanol.   
3.2.3 Magnetic Nanoparticle Uptake  
Bovine Aortic Endothelial cells (BAEC) were seeded on clear-bottom 96-well 
plates at a density of 2.0×104cells per well by using DMEM supplemented with 10% FBS 
and grown until confluence. Dry aliquots of 10%, 30% and 70% (w/w) iron oxide-loaded 
PLA-based MNPs were re-suspended in 100 µL of deionized water and 20 µL of the 
nanoparticle suspension was diluted into 10 mL of 10% FBS supplemented DMEM. This 
MNP suspension was filtered through a Millipore syringe driven filter with 5.0 µm pores 
in order to separate any large non-reconstituted aggregates of MNPs. To synchronize cell 
cultures with respect to MNP uptake, the cells were incubated at 4°C for 30 min. Then 
MNPs were added to cells at different doses, and cell cultures were incubated at 37oC on 
a magnetic separator (LifeSep 96F, Dexter Magnetic Technologies, IL, USA). The 
control (non-magnetic condition) cells were incubated off the magnet.  Further, at 
predetermined time points of 2, 4, 6, 8, 10 and 24 hrs, cells were washed with PBS, and 
the amount of internalized MNPs was measured fluorimetrically (lem/lex = 588/618 nm) 
using a Synergy™ 4 monochromator-based hybrid microplate reader (BioTek, VT, USA).  
The total dose of MNPs initially given to cells was measured at each time point before 
the washing step. Cell viability was determined after 12 hours of MNP uptake by using 
Calcein Green staining and the Alamar blue assay as described by the manufacturer.  
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3.2.4 Cholesterol and Cytochalasin-D Treated Magnetic Nanoparticle 
Uptake 
BAEC cells were seeded in confluency in 96-well sterile cell culture treated plates.  
Cell culture media was aspirated and replaced with PBS containing 0 mM, 5 mM, 10 mM, 
25mM or 50mM methyl-B-cyclodextran solution and incubated for 15 minutes in 37°C.  
Upon completion of the incubation, each well was rinsed three times with PBS. MNP 
uptake experiments were then performed as previously described with cells that were 
either not cholesterol depleted, or cholesterol depleted with 5 mM or 10 mM methyl-B-
cyclodextran solutions.  Cholesterol depletion was confirmed by utilizing the Invitrogen 
Amplex Red cholesterol assay to determine the amount of cholesterol present within the 
cell membrane.  Treated and untreated cells were lysed using the included reaction buffer 
for 30 minutes after incubation with the respective amount of methyl-B-cylcodextran.  
The solution of lysed cells in buffer was then used in accordance with the directions 
included in the kit.  Fluorescence of cholesterol remaining in each well was measured at 
540 nm (excitation) and 590 nm (emission).  For cytochalasin—D uptake experiments, 
cells were treated with 200 nM cytochalasin-D for fifteen minutes prior to uptake 
procedure.  
3.2.5 Cell Viability  
BAECs were grown to confluence in a 24-well plate. Cells were loaded for twelve 
hours with 10%, 30% and 70% MNPs in the influence of a magnetic field.  Calcein green 
stock solution (4 mM) was added to 10 mL of PBS to get a final concentration of 2µM 
calcein-AM solution.  200 µL of this solution was added to each well and imaged with a 
fluorescent microscope. 
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To confirm the visual results and examine cell metabolism, Alamar Blue was 
utilized.  BAECs were grown to confluence in a 96-well plate and loaded for twelve 
hours with 10%, 30% and 70% MNPs diluted to 100%, 75%, 50% and 25% of the initial 
20 µl MNP per 10 ml of cell culture media.  Cells were rinsed three times with PBS and 
cell culture media was replaced with 100 µl of a 10% solution of Alamar Blue In cell 
culture media.  Fluorescence was read at an excitation and emission wavelengths of 560 
nm and 590 nm respectively. 
Lastly, in order to determine whether or not loaded cells were healthy enough to 
be trypsinized, spun down and re-seeded, 70% MNPs were loaded into cells for 24 hours.  
After loading, the cells were spun down and re-suspended and seeded 1:4 in a 24-well 
plate.  Cells were then imaged.   
3.2.6 MNP Quantification 
In order to correlate the percent uptake of particles to the number of particles 
internalized per cell, magnetic nanoparticle cell suspensions were given to a confluent 
culture of bovine aortic endothelial cells, which were further exposed to a magnetic field 
for 12 hours.  Then, the cells were rinsed three times with PBS, trypsinized and collected 
in Eppendorfs.  Control cells (not loaded with magnetic particles) were counted in each 
well by using a hemocytometer and confirmed with Coulter counter to estimate the total 
cell density per well. Eppendorfs containing magnetically laden cells were then 
centrifuged and the remaining pellet was digested with RIPA cell lysis buffer (Pierce 
Biotechnology, USA). After centrifugation step, the iron content was determined 
spectrophotometrically (using SynergyTM 4 multimode plate reader, Biotek, USA and UV 
compatible 96- well plates, BD Bioscienses, USA) in 1N hydrochloric acid (l= 335 nm) 
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against a standard curve after MNP degradation with 1N aqueous sodium hydroxide 
(90°C, 30 min) and dissolution of the iron containing precipitate in the acid solution[12, 
137, 138]. The iron content was correlated to the theoretical iron content in each particle 
in order to determine the approximate number of particles internalized per single cell. 
3.2.7 Statistical Analysis 
Experimental data presented in figures demonstrated the mean ± standard 
deviation.  One-tailed, unequal variance t-tests were used to analyze the significance of 
MNP uptake of various MNP loaded and unloaded cells.  The differences were termed 
significant at p<0.05.  All statistics were performed via Graph Pad Prism software (Graph 
Pad Software Inc., USA). 
3.3 Results  
3.3.1 Magnetic Nanoparticle Synthesis  
 Magnetic nanoparticles were synthesized with magnetite concentrations of 10%, 
30% and 70%. The MNPs hydrodynamic diameters ranged between 213 to 275 nm for 
different magnetite loadings averaging at 239±23 nm (by the dynamic light scattering). 
Size distribution was unaffected by varying magnetite entrapment. Zeta potentials 
indicating the MNPs surface charge were slightly negative and varied between -5.75 and 
-9.27 mV. The resulting PVA-stabilized PLA-based magnetic nanoparticles of various 
magnetite loadings (10-70% (w/w)) exhibited superparamagnetic behavior with no 
significant hysteresis, as previously described in Chapter 2. 
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3.3.2 Magnetic Nanoparticle Uptake  
The uptake of PLA-based magnetic nanoparticles loaded with 10%, 30% and 70% 
(w/w) iron oxide (magnetite) was quantitatively determined by measuring fluorescence of 
internalized MNP fraction to conclude whether variation in magnetite contents within 
particles would affect MNPs uptake into cells when the MNPs and cells were exposed to 
a static magnetic field. For simplicity reasons we will call MNP formulations of different 
magnetite loads as 10, 30 and 70% loaded magnetic nanoparticles. It is noteworthy to 
mention that higher loads of iron oxide resulted in fluorescence quenching of the labeled 
PLA. However, since the fluorescence of taken up fraction of MNPs at each time point 
was normalized to the total fluorescence of each MNP type, the quenching did not affect 
the calculation of the MNP internalization extent. Figure 1A shows that the uptake of 
70% loaded MNP into cells occurred with a quite fast initial rate of ~20%uptake/hour for 
the first four hours almost reaching a saturation (~0.6%uptake/hour) after four hours 
resulting in a ~80% of uptake of the given MNP dose. The initial uptake rates for 30% 
and 10% loaded particles were found to be comparable at about 10.5%uptake/hour and 
8.7%uptake/hour respectively (based on the first eight hours) and were significantly 
(statistics) slower relatively to 70% loaded MNPs. At ten hours, 30% loaded MNPs 
reached similar uptake percentage to that of 70% loaded MNPs. experience similar 
uptake percentages and continue at the same rate for the rest of the observation period, 
reaching a maximum uptake of 91% and 87% respectively after 24hours, while uptake of 
10% loaded MNPs remains well below 30% and 70% loaded MNPs from 6 hours on 
(statistics), reaching a maximum uptake of ~60% after the 24 hour observation period 
(Figure 3.1).  
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Figure 3.1:  The kinetics of 10%, 30% and 70% (w/w) MNP uptake by Bovine Aortic 
Endothelial Cells (BAEC) in culture as a function of incubation time and a magnetic field 
of 500 G “On” by using a fixed magnet applied directly to the underside of the cell 
culture plates. 
3.3.2.A MNP Uptake on and off magnet 
To determine if this uptake is force dependent, magnetic nanoparticle uptake with 
the influence of the magnet was compared to uptake of particles without a magnetic field 
present over the initial 24 hour timeperiod, since they show the greatest differences in 
trend.  The magnetic force can either drive the MNPs into the cell, affect initial 
interctions between the cell membrane and the MNP or facilitate some receptor binding 
events.  When magnetic nanoparticles are taken into the cell without the aid of an 
external field, magnetic nanoparticle uptake significantly decreases for all magnetite 
loadings, Figure 3.2.  The control MNP uptake experiment without exposure to a 
magnetic field resulted in a significantly (statistics) smaller internalization of MNPs 
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within cells for particles of all iron oxide loadings (Figure 3.2). We observed a direct 
correlation between the initial uptake rates and magnetite loadings resulting in maximal 
internalization of MNPs at about 31%, 25% and 11% for the 70%, 30% and 10% loaded 
MNPs respectively.
 
Figure 3.2: The kinetics of 10%, 30% and 70% (w/w) MNP uptake by Bovine Aortic 
Endothelial Cells (BAEC) in culture as a function of incubation time and magnetic field 
off. 
3.3.2.B MNP Uptake with initial magnetic field exposure To  address  the  question  of  whether  or  not  the  increase  in  magnetic nanoparticle uptake  is only  force dependent process, but  is also  influenced by  the availability of MNPs on the cellular surface, we performed uptake experiments with exposure of cells and particles to the magnet for only the first hour, while the rest of the experimental period was carried out “off” the magnetic field. The results of this experiment  show  that  after  the  cells  are  removed  from  a  magnet,  MNP  uptake 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plateaus,  indicating  an  exclusively  force  dependent  mechanism  in  particle internalization, Figure 3.3. 
 
 
Figure 3.3: The kinetics of 10%, 30% and 70% (w/w) MNP uptake by Bovine Aortic 
Endothelial Cells (BAEC) in culture as a function of incubation time and magnetic field 
on for 1 hour then “off”.  
 
3.3.3 Cholesterol Depleted Magnetic Nanoparticle Uptake 
Cholesterol depletion of BAECs was performed to confirm that MNP uptake was 
not via a caveolae-mediated endocytotic mechanism.  In order to deplete the cholesterol 
in the membrane associated with forming caveolae, methyl-B-cyclodextran in three 
different concentrations was used to maximize cholesterol depletion in the membrane 
while causing minimal cell damage.  Invitrogen’s amplex red cholesterol depletion assay 
was used to determine the amount of cholesterol.  After treating cells with 5mM, 10 mM 
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and 25 mM  and 50 mM of methyl-b-cyclodextran for 15 minutes we were able to deplete 
the cholesterol within the cells by up to 97%, Figure 3.4. 
 
 Live-dead staining of cells was performed by using calcein green and imaging the 
cells under a fluorescent microscope.  Calcein green imaging, Figure 2.4, shows that 50 
d
o
s
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Figure 3.4. top) Calcein Green staining of no treatment, 5mM, 10mM 25mM methyl-B-
cyclodextran treated cells bottom) Methyl-B-Cyclodextran was used to deplete 
cholesterol in cellular membrane of BAEC cells.  Cholesterol depletion was able to 
remove up to 97% of the cholesterol.  However, that amount of cholesterol killed all 
cells.  5 mM to 25 mM were healthier doses to the cell 
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mM completely kills all cells exposed to the incubation and 25 mM are significantly less 
viable, therefore, there were eliminated subsequent experiments..  Magnetic nanoparticle 
uptake with 70% MNPs was then completed utilizing the remaining methyl-b-
cyclodextran dosages.  Uptake experiments showed no correlation between cholesterol 
depletion and magnetic nanoparticle uptake Figure 2.5. 
 
Figure 3.5: Magnetic nanoparticle cellular uptake increased with cellular membrane 
cholesterol depletion after 4 hours. 
 
3.3.4 Cytochalasin-D Effects on MNP Uptake 
Cytochalasin- D was used to inhibit actin polymerization in endothelial cells.  By 
inhibiting actin polymerization, the cells can no longer actively uptake MNPs due to the 
importance of the cells cytoskeleton in the process.  When treating BAECs, caution was 
used to not over treat BAEC cells with cytochalasin D.  Cells were treated with 200nM of 
cytochalasin-D.  This dose was enough to see slight deformation of cells, but not so much 
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to initiate cell detachment or death.  Cytochalasin-D treatment significantly impaired the 
ability for BAECs to uptake MNPs both with and without a magnetic influence, Figure 
2.6.  BAECs treated with cytochalasin-D with no magnetic field experienced the no 
change, three times less uptake and two and a half times less uptake respectively for 10%, 
30% and 70% MNPs compared to their non-treated counterparts.  Cells treated with 
cytochalasin-D and exposure to a magnetic field experienced fifteen, four and three and a 
half times less for 10%, 30% and 70% MNPs in comparison to their non-treated 
counterparts. 
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Figure 3.6: top) 10%, 30% and 70% MNP uptake of cells treated with 200nM of 
cytochalasin-D under the influence of a magnetic field. Bottom) 10%, 30% and 70% 
MNP uptake of cells treated with 200nM of cytochalasin-D without the influence of a 
magnetic field.  There is a clear significant difference (p<0.001) between non-treated 
cells and cytochalasin-D treated cells both on and off the magnet. 
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3.3.5 Calcein Green Staining After Loading 
Live cell staining was performed using CellTraceTM calcein green AM reagent. In 
live cells the nonfluorescent CellTrace calcein green AM is converted to a green-
fluorescent calcein after intracellular esterases remove the acetoxymethyl (AM) esters. 
The magnetic nanoparticles were internalized within the cells on a magnet for twelve 
hours. Live cells were stained green (488/530 nm), while magnetic nanoparticles 
exhibited red fluorescence (588/617 nm).   Figure 2.7 shows no significant differences in 
cell viability for all magnetite loadings comparing to the control cells not treated with 
MNPs.   
Figure 3.7: Micrographs of Bovine Aortic Endothelial Cells (BAECs) in green and red 
fluorescent channels qualitatively showing the relative amount of 10%, 30% and 70% 
magnetite loaded MNPs internalized within cells at 12 hour time point. Control cells were 
not treated with MNPs. Green fluorescent micrographs show healthy cells as assessed by 
calcein green staining. (Magnification:x100.) 
Control 10% MNP 30% MNP 70% MNP 
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3.3.6 Alamar Blue of Cells after Loading 
  To further examine MNP compatibility within cells, we utilized the Alamar Blue 
assay 48 hours after the conclusion of magnetic nanoparticle incubation. The MNP 
uptake was conducted for 12 hours using various dilutions of MNPs. Figure 2.8 shows 
that a maximum of 15% in fluorescence variation relatively to control cells was measured 
for particles of all loadings at different dilutions.  The maximal dose used in these 
experiments showed 89±7% survival for 10% loaded MNPs, 86±1% survival for 30% 
loaded MNP and 85±10% for 70% loaded MNP. 
 
Figure 3.8: Alamar Blue assay for Bovine Aortic Endothelial cells (BAEC) loaded for 12 
hours with 10%, 30% and 70% MNPs and various dilutions. The Alamar Blue assay was 
performed 48 hours post loading with MNPs.  Cell survival is presented as a fraction 
relatively to control, unloaded cells.  
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3.3.7 Ability to Re-plate cells after loading 
After 12 hours, the cells were imaged with a light-microscope.  Figure 2.9, shows 
that MNP loaded cells could be re-seeded and attach as healthy cells would. 
 
Figure 3.9: 70% MNP loaded for 12 hours into bovine aortic endothelial cells after 
trypsinization and re-seeding 
3.3.8 Magnetic Particle Quantification 
 The amount of magnetite uptake into cells was found by spectrophotometry 
measuring specific absorption of iron at 335 nm as previously described in the literature 
[137]. The amount of magnetite internalized within the cells that were loaded with 10%, 
30% and 70% MNPs was found to be 10.0±5.0 ng/cell, 19.0±6.0 ng/cell and 50.0±10.0 
ng/cell respectively. These numbers were used along with theoretical calculations based 
on MNP geometry (assuming an average MNP diameter of 300 nm,[137, 138]) to 
determine the number of magnetic nanoparticles incorporated into a single cell.  Cells 
loaded with 10%, 30% and 70% MNPs for 12 hours were found to have accumulated 
approximately 10,000 MNPs/cell, 16,000 MNPs/cell and 35,000 MNPs/cell respectively.  
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Therefore, MNPs incorporation into a single cell took up approximately 3%, 5% and 12% 
of the cell’s total volume respectively. 
3.4 Discussion 
The aim of this study was to evaluate the effects of magnetic forces acting on 
cells with respect to the MNP internalization kinetics and mechanism. To understand 
whether the MNP uptake into cells is a force dependent process. Additional questions of 
interest here are how cells tolerate high doses of MNPs and whether the high MNP loads 
would affect BAECs. This information is of high relevance for magnetically-mediated 
cell targeting applications where the responsiveness of MNPs is an important parameter 
to allow efficient targeting. On the other hand the cytocompatibility of MNPs with cells 
is also a very important prerequisite in magnetic cell targeting applications because 
targeted cells are expected to provide a therapeutic effect at the target site, either by 
restoration of a physiologically normal cellular layer (stent applications or cardiac tissue 
applications), secreting regulatory factors or “drugs” utilizing cellular machinery 
mechanisms.   
3.4.1 Magnetic Nanoparticle Synthesis 
To understand how magnetic forces affect MNP uptake kinetics and 
internalization mechanism, we formulated magnetic nanoparticles of distinctive 
theoretical magnetite loads of 10%, 30% and 70% (w/w). In our earlier studies we found 
that for 10% and 30% magnetite loaded particles the efficiency of incorporation was 
about 95% (MacDonald, Johnson). In this study, we found that for 70% magnetite loaded 
particles the efficiency of incorporation was about 90%. These high magnetite 
incorporation efficiencies indicate on an adequate level of magnetic material loading 
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matching well the expected theoretical vales. Particles of all loads exhibited a mean 
hydrodynamic diameter in a range 250-310 nm, which indicates that magnetite loadings 
did not affect particle size.  
With regards to zeta potential, each of these magnetite loadings had a negative 
zeta potential of -6.8 mV, -6.95 mV and -9.27 mV for 10%, 30% and 70% loadings.  
Highly negatively charged MNPs would typically not be well incorporated into cells due 
to the negatively charged endothelial cell membrane, however, our MNPs exhibit low 
negative zeta potentials.  Our MNPs exhibit standard superparamagnetic properties, as 
shown in chapter two. 
3.4.2 Magnetic Nanoparticle Uptake 
   
 We expect that the force exerted on an endothelial cell by a MNP exposed to a 
magnetic field will increase as iron oxide concentration within the particle increase.  Our 
results show that 250-310 nm MNPs internalize within endothelial cells at different rates, 
depending on the magnetite incorporation per particle (Figure 3.1).  This indicates that 
the uptake mechanism used by the cell is force dependent.  Our results also indicate that  
MNPs are also taken into the cell without the influence of a magnetic field, therefore, it 
was important to examine if the magnetic field actually stimulates uptake because of the 
force it is applying on a cell, or whether it just allows the MNPs to reach a surface of the 
cell at a faster rate. To examine this phenomenon, we conducted an experiment where  
MNPs given to cells were exposed to a magnet for only one hour (a sufficient time to 
sediment >90% of MNPs). We found that before removal of the magnet  (1 hour time 
point), the MNP uptake rates were similar to those seen in previous experiments, 
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however, after the removal of the magnet, MNP uptake was stalled and the uptake rate 
plateaued for the remainder of the observation period.  This result also supports that MNP 
uptake is force dependent process and not an effect of the magnetic field allowing MNPs 
quicker access to the cell-surface. No further increase in MNP uptake after removal of the 
magnet at a 1 hour time point shows that internalization of a fraction of MNPs (21%,  
10% and 4% uptake for 70%, 30% and 10% loaded particles respectively, Figure 3.3) 
cause cells to reach saturation with no further ability to internalize more particles. These 
levels of uptake correlate well with the final uptake extents in the non-magnetic uptake 
experiment (Figure 3.2). This result show that without the magnetic field cellular ability 
to internalize particles is limited, however when magnetic field is applied, the magnetic 
forces will cause MNPs penetrate the cell allowing almost full MNP dose internalization.     
3.4.3 Treated Cells Magnetic Nanoparticle Uptake   We expect that the force exerted on an endothelial cell by a MNP exposed to a 
magnetic field will increase as iron oxide concentration within the particle increase.  Our 
results show that 250-310 nm MNPs internalize within endothelial cells at different rates, 
depending on the magnetite incorporation per particle (Figure 3.1).  This indicates that  
the uptake mechanism used by the cell is force dependent.  Our results also indicate that  
MNPs are also taken into the cell without the influence of a magnetic field, therefore, it  
was important to examine if the magnetic field actually stimulates uptake because of the  
force it is applying on a cell, or whether it just allows the MNPs to reach a surface of the  
cell at a faster rate. To examine this phenomenon, we conducted an experiment where  
MNPs given to cells were exposed to a magnet for only one hour (a sufficient time to  
sediment >90% of MNPs). We found that before removal of the magnet  (1 hour time  
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point), the MNP uptake rates were similar to those seen in previous experiments,  
however, after the removal of the magnet, MNP uptake was stalled and the uptake rate 
Previous research examining endocytosis of nanoparticles, magnetic or otherwise, 
points to clathrin-mediated endocytosis for particles less than 200 nm in diameter and 
caveolae-mediated endocytosis as the most probable candidate for endocytosis of 
particles greater than 200 nm in diameter.  Our particles are larger than those that we 
would expect to see internalized via clathrin-mediated pathways, therefore, methyl-β-
cyclodextran, a common caveolae-mediated endocytosis inhibitor was used during MNP 
uptake to deplete the BAEC cell membrane of cholesterol.  Since caveolae are enriched 
with cholesterol, theoretically, depleting the membrane of cholesterol would in turn 
minimize the number of caveolae present in the membrane; therefore, reducing the 
number of MNPs a cell is able to take in.  Our results however, show that cholesterol 
depletion of the cells does not affect MNP uptake into cells, suggesting that MNP uptake 
into endothelial cells is not a caveolae-mediated process.   
Cytochalasin-D affects the actin polymerization in the cytoskeleton of endothelial 
cells by binding to the ends of microfilaments, which in turn prevents assembly and 
disassembly of actin monomers.  As a result, it inhibits the binding phase in phagocytosis.  
When our cells were treated with Cytochalasin-D MNP uptake was severely inhibited 
with and without the influence of a magnetic field.  This suggests that MNP uptake is in 
fact a force-mediated active process.  We would suspect that the cytochalasin-D would 
cause a weakening in the stiffness of the cellular membrane, therefore, allowing MNPS to 
penetrate much easier.  However, we find that cytochalasin-D actually inhibits MNP 
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uptake, indicating that the uptake process is not only an active process but also dependent 
upon the force the MNP induces on the membrane. 
It is important to note that altering either cholesterol or actin filaments in an 
endothelial cell can seriously alter the standard endocytotic mechanisms of a cell.  
Therefore, the suggestions made in regards to the mechanism of uptake of these particles 
must be further examined.  At this point in time, there are no clear methods to block the 
endocytotic pathways that we are examining for particle uptake of our size that do not 
alter standard cell function.   
3.4.4 Calcein Green Imaging of Loaded Cells  
To determine the health status of MNP-loaded cells, images of BAEC fully-
loaded with MNPs exhibit the same cell density and morphology as control cells not 
loaded with particles.  Fluorescent images of the MNPs internalized within cells after 12 
hours correspond well with the fluorescent uptake data found in the uptake experiments 
and calcein green staining shows no detrimental effects to the cell.  
3.4.5 Alamar Blue Fluorescence of Loaded Cells  
Alamar Blue fluorescence of loaded cells with varying dilutions of the standard 
20 µl MNP per 10 ml of cell culture media was examined in comparison to control cells.  
Cells loaded with 10% MNPs diluted to 25% and 50% showed viability above 90% in 
comparison to control.  All other MNP loadings and dilutions showed viability 85% in 
comparison to control.  Overall, Alamar Blue results were in agreement with Calcein 
Green images of the cells. This indicates that 48 hours post uptake process cells preserve 
their healthy state showing a very marginal decrease in number of viable cells.  
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3.4.6 Ability to Reseed after Loading 
While preliminary viability tests indicate relatively healthy cells, an important 
characteristic of magnetically loaded endothelial cells for drug delivery or targeting 
would be the ability to load them and utilize them as one would standard cells. That 
means that the ability to trypsinize and reseed or release into the body is necessary.  To 
be certain that we can treat MNP loaded cells as we would non-loaded cells, we 
trypsinized, spun down re-suspended and reseeded MNP loaded endothelial cells to be 
certain that the high MNP loading of 70% MNPs after 12 hours did not affect their ability 
to survive the vigorous process.  Our results show that these MNPs successfully survive 
the standard re-suspension and re-seeding process. 
3.4.7 Magnetic Nanoparticle Quantification 
 To find the approximate number of magnetic nanoparticles present in a single cell, we 
utilized the known mean diameter of MNPs as well as iron content information obtained 
after loading in conjunction with the theoretical values we would obtain from the 
chemical equations and protocol of MNP formulation.  We found that after 12 hours of 
loading, MNPs comprised approximately 3%, 5% and 12% of the entire endothelial cells 
volume.  This value can be considered a lower level limit given a few assumptions made 
throughout the quantification process. MNPs were loaded in 96-well plates, however, 
given the nature of the LifeSep magnetic plate, particles were loaded mainly through the 
centerline of the well.  Therefore, the cells on the outside edges were not loaded nearly as 
highly as those in the center.  The iron content found in those center cells was spread out 
amongst all of the cells in the well, therefore, giving us a slightly lower value than what 
might be expected.  
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3.5  Conclusion 
      The aim of this study was to evaluate the effects of magnetic forces acting on cells 
with respect to the MNP internalization kinetics and mechanism. To understand whether 
the MNP uptake into cells is a force dependent process? Additional questions of interest 
here are how cells tolerate high doses of MNPs and whether the high MNP loads would 
interfere with cellular functions? This information is of high relevance for magnetically-
mediated cell targeting applications where the responsiveness of MNPs is an important 
parameter to allow efficient targeting. On the other hand the cytocompatibility of MNPs 
with cells is also a very important prerequisite in magnetic cell targeting applications 
because targeted cells are expected to provide a therapeutic effect at the target site, either 
by restoration of a physiologically normal cellular layer (stent applications) or tissue 
(cardiac tissue applications? other ideas), secreting regulatory factors or “drugs” utilizing 
cellular machinery mechanisms (ref for gene therapy). To understand how magnetic 
forces affect MNP uptake kinetics and internalization mechanism, we formulated 
magnetic nanoparticles of distinctive theoretical magnetite loads of 10%, 30% and 70% 
(w/w). In our earlier studies we found that for 10% and 30% magnetite loaded particles 
the efficiency of incorporation was about 95% (MacDonald, Johnson). In this study, we 
found that for 70% magnetite loaded particles the efficiency of incorporation was about 
90%. These high magnetite incorporation efficiencies indicate on an adequate level of 
magnetic material loading matching well the expected theoretical vales. Particles of all 
loads exhibited a mean hydrodynamic diameter in a range 250-310 nm, which indicates 
that magnetite loadings did not affect particle size. 
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      We expect that the force exerted on an endothelial cell by a MNP exposed to a 
magnetic field will increase as iron oxide concentration within the particle increase.  Our 
results show that 250-310 nm MNPs internalize within endothelial cells at different rates, 
depending on the magnetite incorporation per particle (Figure 1A).  This indicates that 
the uptake mechanism used by the cell is force dependent.  Our results also indicate that 
MNPs are also taken into the cell without the influence of a magnetic field, therefore, it 
was important to examine if the magnetic field actually stimulates uptake because of the 
force it is applying on a cell, or whether it just allows the MNPs to reach a surface of the 
cell at a faster rate. To examine this phenomenon, we conducted an experiment where 
MNPs given to cells were exposed to a magnet for only one hour (a sufficient time to 
sediment >90% of MNPs). We found that before removal of the magnet  (1 hour time 
point), the MNP uptake rates were similar to those seen in previous experiments, 
however, after the removal of the magnet, MNP uptake was stalled and the uptake rate 
plateaued for the remainder of the observation period.  This result also supports that MNP 
uptake is force dependent process and not an effect of the magnetic field allowing MNPs 
quicker access to the cell-surface. No further increase in MNP uptake after removal of the 
magnet at a 1 hour time point shows that internalization of a fraction of MNPs (21%, 
10% and 4% uptake for 70%, 30% and 10% loaded particles respectively, Figure 1C) 
cause cells to reach saturation with no further ability to internalize more particles. These 
levels of uptake correlate well with the final uptake extents in the non-magnetic uptake 
experiment (Figure 1B). This result show that without the magnetic field cellular ability 
to internalize particles is limited, however when magnetic field is applied, the magnetic 
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forces will cause MNPs penetrate the cell allowing almost full MNP dose 
internalization.     
      To determine the health status of MNP-loaded cells, images of BAEC fully-loaded 
with MNPs exhibit the same cell density and morphology as control cells not loaded with 
particles.  Fluorescent images of the MNPs internalized within cells after 12 hours 
correspond well with the fluorescent uptake data found in the uptake experiments and 
calcein green staining shows no detrimental effects to the cell. Alamar Blue fluorescence 
of loaded cells with varying dilutions of the standard 20 µl MNP per 10 ml of cell culture 
media was examined in comparison to control cells.  Cells loaded with 10% MNPs 
diluted to 25% and 50% showed viability above 90% in comparison to control.  All other 
MNP loadings and dilutions showed viability 85% in comparison to control.  Overall, 
Alamar Blue results were in agreement with Calcein Green images of the cells. This 
indicates that 48 hours post uptake process cells preserve their healthy state showing a 
very marginal decrease in number of viable cells. 
      While preliminary viability tests indicate relatively healthy cells, an important 
characteristic of magnetically loaded endothelial cells for drug delivery or targeting 
would be the ability to load them and utilize them as one would standard cells. That 
means that the ability to trypsinize and reseed or release into the body is necessary.  To 
be certain that we can treat MNP loaded cells as we would non-loaded cells, we 
trypsinized, spun down re-suspended and reseeded MNP loaded endothelial cells to be 
certain that the high MNP loading of 70% MNPs after 12 hours did not affect their ability 
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to survive the vigorous process.  Our results show that these MNPs successfully survive 
the standard re-suspension and re-seeding process. 
            To find the approximate number of magnetic nanoparticles present in a single 
cell, we utilized the known mean diameter of MNPs as well as iron content information 
obtained after loading in conjunction with the theoretical values we would obtain from 
the chemical equations and protocol of MNP formulation.  We found that after 12 hours 
of loading, MNPs comprised approximately 3%, 5% and 12% of the entire endothelial 
cells volume.  This value can be considered a lower level limit given a few assumptions 
made throughout the quantification process. MNPs were loaded in 96-well plates, 
however, given the nature of the LifeSep magnetic plate, particles were loaded mainly 
through the center line of the well.  Therefore, the cells on the outside edges were not 
loaded nearly as highly as those in the center.  The iron content found in those center 
cells was spread out amongst all of the cells in the well, therefore, giving us a slightly 
lower value than what might be expected. 
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Chapter 4:  Magnetically loaded endothelial cells for targeted drug 
delivery applications 
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4.1 Background 
Magnetic nanoparticles (MNPs) are continuously examined as part of 
biotechnologies growing interest in nanotechnology[139, 140].  Currently, MNPs have 
been shown to be useful in gene delivery, imaging and diagnostics ([12, 140-143]), with 
the main application being their use as contrast agents in Magnetic Resonance Imaging 
(MRI)[14].  Aside from these standard purposes, nanoparticles are an attractive option for 
drug delivery, due to the ease of surface functionalization and biocompatibility [24, 141, 
144, 145].  
  Given the ease at which we can load magnetic nanoparticles, cells loaded with 
MNPs as vectors for targeted drug delivery can potentially eliminate the difficulties of 
circumventing the immune system of the human body.  Previous work has shown that 
MNP loaded endothelial cells are promising vectors for targeted delivery to 
cardiovascular stents[45-50].  In our work we show the feasibility of using these MNP 
loaded cells to increase transport through non-fluid model systems of the human body, 
utilizing a 3-D migration system.   
Furthermore, our research investigates whether high loading of MNPs alters the 
function of the endothelial cells.  Our studies examine cytoskeletal function upon high 
loading of these cells.  The ability to keep the natural function of the cells intact with high 
loading allows us to obtain highly magnetic responsive bodies that can be utilized in 
targeted cell delivery for drug delivery or tissue culture functions.   
   81 
4.2 Materials and Methods 
4.2.1 Confocal Imaging 
Bovine aortic endothelial cells were seeded in 35 mm glass bottom dishes 
(MatTek Corp, Ashland, MA, USA). 10%, 30%, 70% and control solutions were 
prepared as discussed in chapter two, with 20 µL of the fluorescent MNP suspension in 
10 ml of 10% FBS DMEM.  Four dishes were used for each magnetite concentration 
MNP solution.  2 ml of each solution was placed in the glass bottom dish and the dishes 
were placed on the LifeSep magnet.  For each of the control, 10%, 30% and 70%, the 
dishes were rinsed three times prior to visualization of the uptake using Drexel 
University’s Olympus FluoView FV1000 confocal laser scanning inverted confocal 
microscope. 
4.2.2 Mitochondria Imaging  
 Mitotracker Green and Mitotracker Orange were obtained from Invitrogen (San 
Diego, CA, USA). Bovine Aortic Endothelial cells were seeded in 35 mm glass bottom 
dishes.  MNP solutions were added and incubated on a magnet for 12 hours. Mitotracker 
Green and Mitotracker Orange were dissolved in HEPES buffer with final concentrations 
of 70 nM and 25 nM respectively.   2 ml of the combined Mitotracker stains were added 
to each glass bottom dish, covered with foil, and incubated at room temperature for 30 
minutes.  Confocal images were taken. 
Mitochondria titrations were completed utilizing carbonyl cyanide m-chlorophenyl 
hydrazine (CCCP).  BAECs loaded with MNPS for 12 hours were then treated with 
Mitotracker Orange and Mitotracker Green.  Confocal images were taken every 2 
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seconds over a 5 minutes time period.  Two separate doses of CCCP were added, the first 
dose of 0.2 µM at 100 seconds and the second dose of 0.4 µM at 200 seconds.  Intensity 
of Mitochondria Orange was monitored over the 5 minute time period. 
4.2.3 Actin Imaging 
We utilized a standard transfection protocol using GenDrill (BamaGen 
Biosciences, Gaithersburg, MD, USA) to image actin filaments in our BAEC cells.  
BAEC cells were grown to confluence in a 35mm glass bottom dish.  MNP solutions of 
10%, 30% and 70% MNPs were added and allowed to incubate for 12 hours.  To begin 
the transfection process, we diluted 1 µg of DNA (equivalent to 2.5 µl of β-actin) in 100 
µl of serum-free cell culture media.  3µl of GenDrill was diluted into 100 µl of serum free 
cell culture media. The GenDrill solution added to DNA mixture and vortexed.  This 
solution was incubated at room temperature for 15 minutes.  To each plate of control and 
MNP loaded cells, 500 µl of serum free cell culture media was used and 200 µl of the 
transfection mixture was added drop wise.  The BAEC cells along with transfection 
mixture and serum-free media were incubated for five hours at 37°C.  At the completion 
of the incubation, 1 ml of cell culture media supplemented with 10% FBS was added to 
the plates and cells were incubated at 37°C for 24 hours.  Cells were then imaged using 
the confocal microscope. 
4.2.4 Cytoskeletal Function – 2-D Migration 
Bovine aortic endothelial cells were seeded on gridded cover slips from Electron 
Microscopy Sciences (Hatfield, PA, USA) with the aid of a cloning ring (VWR, Radnor, 
PA, USA).  The cloning ring was placed in the center of the gridded cover slip and cells 
were seeded in the interior of the cloning cylinder.  Cells were allowed to reach 
   83 
confluence and then the cell culture media inside the cloning cylinder was replaced with 
100 µL of magnetic nanoparticle suspension.  A cylindrical neodymium magnet was 
placed underneath of each well to load magnetic nanoparticles within cells.  After 12 
hours of cell loading on the magnet, the cloning ring was removed and cells were rinsed 
three times with PBS before beginning the migration assay.  Migration of the cells was 
measured by using light microscopy with the gridded coverslip to measure the distance 
cells traveled over a 45 hour time period.   
4.2.5 Model Targeting – 3-D Migration 
Fluoroblok transwell inserts were coated with 100µg/ml type-I collagen from 
Sigma-Aldrich (St. Louis, MO, USA) and allowed to set for one hour and then rinsed 
with PBS.  BAEC cells were loaded for 12 hours with 70% (w/w) magnetite containing 
MNPs.  Control (not leaded) cells and magnetically loaded cells were then trypsinized 
and seeded in 5% FBS supplemented DMEM in the apical chamber of a 24-well 
Fluoroblok transwell insert at 100,000 cells/well.  The basal section of the transwell 
insert contained either 5% or 10% FBS supplemented DMEM in order to induce cell 
migration through the collagen coated membrane.  Control cells and magnetically loaded 
cells were then allowed to migrate in each condition and either in a control condition or 
one with a static magnetic field from a neodymium magnet.  After 12 hours of migration, 
the basal section of the well was aspirated and Calcein Green was applied to stain cells.  
Fluorescent images were then taken to determine the extent of migration that occurred in 
each well.   Further magnified images were taken at four random locations in order to 
quantify the number of cells that had migrated through the membrane.  
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4.2.6 Statistical Analysis 
 As stated before, experimental data presented in figures demonstrated the mean 
± standard deviation.  One-tailed, unequal variance t-tests were used to analyze the 
significance of migration distances and quantities of loaded and unloaded cells.  A linear 
regression was used to demonstrate the rate of migration (in 2D experiment) of control 
and MNP loaded cells and determine whether the rates of uptake were significantly 
different. In 3D migration experiment two-way ANOVA was run for comparisons of 
multiple groups. In all tests, the differences were termed significant at p < 0.05 and the 
degree of significance is given in figures when appropriate (*, p<0.05; ** p<0.01; 
*** p<0.001).  A segmented linear regression was used to compare the mitochondrial 
analysis with CCCP.  All statistics were performed via Graph Pad Prism (Graph Pad 
Software Inc., USA).  
4.3 Results 
4.3.1 Confocal Imaging 
MNP formulations of 10%, 30% and 70% were loaded into cells for 12 hours 
under the influence of a magnetic field for 1 hour, 4 hours and 10 hours.  Magnetic 
nanoparticle uptake into BAEC cells was confirmed via confocal imaging, Figure 4.1.  
These images show the density of loading of MNPs.  The z-stack of loaded cells shows 
MNP incorporation within the cell.  Earlier time points, after one hour, showed uptake in 
Chapter 2.  To confirm that MNPs were within the cell at these time points and not just 
associated with the membrane, confocal slices were examined.  MNPs were proven to be 
within the cell for all time points and particle formulations with the exception of 10% 
after 1 hour, Figure 4.2 
   85 
. 
 
Figure 4.1: Confocal images of MNP uptake.  10%, 30% and 70% MNPs incubated for 1, 
4 and 10 hours respectively.  Images represent Z-stack. 
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Figure 4.2: Magnetic Nanoparticle uptake for 10%, 30% and 70% MNPs after one hour.  
Shows top, middle and bottom slices of the z-stack.  MNPs not located in the center or 
bottom slices of the z-stack are assumed to be associated with the membrane and not yet 
fully internalized by the endothelial cells. 
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4.3.2 Mitochondria Imaging  
Mitotracker Green and Orange were used to fluorescently label high membrane 
potential mitochondria (orange) and all other mitochondria (green) of control and 10%, 
30% and 70% MNP loaded cells incubated for twelve hours prior to being imaged via 
confocal microscope.  After examining the initial images of our MNP loaded cells, that 
MNP loading on cells appeared to increase the number of actively respiring mitochondria 
in the cell in comparison to the Mitotracker-Green to Orange ration seen in control cells, 
Figure 4.3 
 
Figure 4.3:  MNP uptake into cells increased the number of actively respiring 
mitochondria with respect to the mass.  The ratio of Mitotracker red (actively 
respiring)/Mitotracker green (present but not actively respiring mitochondria) increases 
with the addition of MNPs into BAEC cells.  All loaded BAEC (n=5) were statistically 
different from the control (p<0.05). 
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To examine whether or not these were negative effects on the cell, titrations with 
CCCP, a mitochondrial membrane depolarizer was used to show negatively affected 
mitochondria.  Images were taken after CCCP doses of 0.6 µM and 1.4 µM were used to 
uncouple the mitochondrial membrane, Figure 4.4 
 
Figure 4.4: Bovine aortic endothelial cells loaded with 10%, 30% or 70% MNPs for 12 
hours.  Cells were stained with Mitotracker-Orange to label high membrane potential 
mitochondria and Mitotracker-Green to label the remaining mitochondria.  Shows the 
presence of each type of mitochondria and how the loaded cells are affected when 
exposed to a 0.5µM followed by 1.4 µM dose of CCCP, a mitochondrial membrane 
uncoupler. 
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Fluorescent Intensity of Mitotracker orange in each cell in the confocal frame was 
measured over time during the addition of CCCP, Figure 4.5.  Each time a CCCP dose 
was added the fluorescent intensity of the Mitotracker dropped, indicating depolarization 
of the mitochondrial membrane and thus a decrease in the mitochondria’s ability to 
actively respire. 
 
Figure 4.5: Mitotracker-orange intensity profiles over time of control and MNP BAEC 
cells loaded with 10%, 30% and 70% MNPs for 12 hours in response to two doses of 
CCCP a 0.2 µM and 0.4 µM dose after 100 and 200 seconds respectively. 
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The intensity values for each cell and each time point were normalized to the 
initial intensity.  These values were plotted using a 2nd order smoothing, following the 
Savistsky-Golay smoothing principles, Figure 4.6.  A segmented linear regression was 
used to compare the lines after the dose of CCCP was added at t = 100 seconds.  The 
segmented linear regression showed that the decrease in mitotracker-red intensity was 
similar for the control and 30% MNP loaded cells (p>0.05) and similar for 10% and 70% 
MNP loaded cells (p>0.05).  However, when comparing loaded cells to control cells, only 
30% loaded MNPs mitochondrial response acted similarly to control cells.  
 
Figure 4.6:  Titration curve of control cells and MNP loaded cells after titrating with 
CCCP concentrations.  The first dose of 0.6 µM CCCP was added at 100 seconds, while 
the second dose of 1.4 µM was added at 200 seconds.   
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4.3.3 Actin Imaging 
BAECs were transfected with DNA to have fluorescently labeled actin filaments.  MNPs 
were loaded for 12 hours on a magnet prior and then imaged under the fluorescent scope. 
Images show that actin filaments do not seem to be damaged, but merely parted so that 
MNP aggregates can take up space, Figure 4.7.  However, it is important to note that this 
analysis is subjective in nature so further studies will be completed to further demonstrate 
actin function. 
 
Figure 4.7:  Transfected DNA into BAEC cells led to fluorescent actin filaments. Actin 
filaments of Control, 10%, 30% and 70% loaded MNPs were stained and show similar 
morphologies in comparison to control cells. 
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4.3.4 Cytoskeletal Function – 2-D Migration Migration studies were performed without the influence of magnetic field as a  re‐assurance  that  the magnetic nanoparticles were not affecting  the cytoskeletal functions.  Migration distance was statistically different (p< 0.001) from the control for cells loaded for twelve hours with 10% or 70% MNPs Figure 4.8.  However, the difference was  not  inhibitory.    An  increase  in MNP  loadings  led  to  an  increase  in migration distance with the exception of 30% MNP loaded cells  ,which exhibited a similar migration distance as that of control cells.  Images of the migration distance were  taken  via  light  microscope  and  image  analysis  was  used  to  quantify  the distance traveled by the furthest cell, Figure 4.9. 
 
Figure 4.8:  BAEC cells were loaded with 70% MNPs for 12 hours before being placed 
into a Transwell insert for 3-D migration.  Migration was performed under the influence 
of a static magnetic field and without the influence of a magnetic field for loaded cells 
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and the migration was compared to control, unloaded cell migration. Migration was 
monitored for 12 hours and 24 hours to compare with a change in FBS as a positive 
control. In comparison to control cell migration, both 10% and 70% MNP loadings were 
statistically different (p<0.001).  However, migration of 30% loaded BAEC was similar 
to that of control cell migration (p>0.05). 
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Figure 4.9:  BAEC migration assays.  Control cells and 10%, 30% and 70% MNP loaded 
migrations.  Note that the 48-hour migration image of the 70% loaded cells proceeded to 
the next grid. 
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4.3.5 Model Targeting – 3-D Migration 
70% MNP loading into cells was used since these particles exhibited the largest 
magnetic gradient and maximal loading that we could get in the time period, therefore 
leading to a more intense magnetic response.  The magnetic field placed below the 
transwell membrane (Figure 4.10a) allowed us to image from the bottom only the cells 
that had migrated through the Fluoroblok wells that block the fluorescence of cells 
located on top of the membrane.  3-D migration showed that magnetically loaded cells 
exposed to a magnetic field migrated at an increase rate in comparison to control cells 
exposed to a FBS concentration difference.    This can be seen in calcein green imaging, 
Figure 4.10b,  and also image analysis of the number of cells that migrate through, Figure 
4.11.     
Magnetically loaded cells migrated significantly faster when under the infuence of 
a magnetic field as seen in the images and confirmed with image analysis and cell counts.  
Examining five frames of reference magnetically loaded cells exposed to a magnet 
showed 2.5 times more migration than that of control cells after 24 hours.  FBS 
concentration differences were used as a positive control and magnetic nanoparticles 
exposed to a magnet without a FBS change also showed more migration in comparison to 
control cells with an FBS concentration change.  Lastly, magnetically loaded cells not 
exposed to a magnetic field exhibited results statistically similar (p>0.2) to control cells. 
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Figure 4.10: a) BAEC cells were loaded with 70% MNPs for 12 hours before being 
placed into a Transwell insert for 3-D migration.  Image of setup is shown.  Migration 
was performed under the influence of a static magnetic field and without the influence of 
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a magnetic field for loaded cells and the migration was compared to control, unloaded 
cell migration. 4.10 b) Migration was monitored for 12 hours and 24 hours to compare 
with a change in FBS as a positive control. 
 
 
Figure 4.11:  BAEC cells loaded with70% MNPs for 12 hours showed an increased 
migration under the influence of a magnetic field through an 8 µm pore Transwell 
membrane.  The positive migratory control was differing FBS concentrations in the 
apical versus basal compartments of the Transwell set up.  When comparing the above 
values we find that there is a significant difference (p<0.001)  between magnetically 
loaded cells with our without a FBS gradient on a magnet in comparison to control cells 
without a FBS gradient.  The addition of the magnetic field to loaded cells with our 
without a FBS gradient provides similar (P>0.05) migration values as that of control cells 
with an FBS change. 
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4.4 Discussion 
4.4.1 Confocal Imaging 
Confocal imaging was performed to determine if particle volume calculations 
from Chapter two were correlated with the image results and to determine the location of 
MNPs within endothelial cells.  After 1 hour of loading, images demonstrate an 
interesting phenomenon for 10% and 30% MNPs.  For these MNP formulations uptake is 
minimal.  So minimal, that upon further investigation, MNPs are not in fact incorporated 
into the cell, but associated with the cell membrane.   
 At 4 hour and 10-hour time points for 10% and 30% and all 70% time points, 
magnetic nanoparticles exhibited perinuclear accumulation within the cell and are 
aggregated into small pockets within the cell.  MNP loading for 4 hours and 10 hours in 
30% and 70% MNPs is so extensive that MNP loading fills the cell from the perinuclear 
area to the cell membrane.  
4.4.2 Mitochondria Imaging  
Mitochondria health is important to a cells well being, given that they are 
responsible for cellular respiration and ATP production.  Without healthy mitochondria, 
the cell will die.  After confocal images showed BAECs highly loaded with MNPs, it was 
determined that a look at mitochondria health was important to show that the cells were 
not “suffocating”.  In order to examine the health of the mitochondria we looked at 
mitochondrial membrane potential, ΔΨ, with the help of two fluorescent probes, 
Mitotracker-Green and Mitotracker-Orange.  Mitotracker-Orange, reflects mitochondrial 
oxidative capacity and only penetrates into mitochondria with high ΔΨ.  Mitotracker-
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Green penetrates into all mitochondria, including those with low ΔΨ, and is therefore 
often used as a measure of total mitochondria within a cell.  We looked at the ratio of the 
fluorescent intensities of Mitotracker Orange to Mitotracker Green as a metabolic index 
representing the proportion of actively respiring mitochondria in the total mitochondrial 
mass. 
Our results showed that an after 12-hours of MNP loading into BAECs, the ratio 
of high membrane potential mitochondria to low membrane potential mitochondria is 
extremely high, in comparison to control cells where the ratio is approximately one, 
indicating that all mitochondria in the cell are operating at full capacity in attempt to 
respire as a result of high MNP loading. 
In order to be certain that mitochondria were still actively functioning, CCCP was 
used as a negative control to show how the fluorescent intensity of the Mitotracker 
orange would be affected the presence of a mitochondrial membrane-uncoupling agent. 
CCCP was used to measure the sensitivity of depolarization of the mitochondrial 
membrane.  Our images showed that for control, 10%, 30% and 70% MNP loaded cells, 
ΔΨ, was decreased after an initial dose of 0.6 µM CCCP, but was then restored after 
some time, suggesting that neither collapse of ΔΨ or depolarization of the mitochondria 
occurred.  A linear regression of this segment of the graph showed that there was no 
significant difference between loaded and non-loaded cells (p>0.05).  However,   after the 
second dose of 1.4 µM CCCP, there was a steep decrease in ΔΨ, indicating loss of 
mitochondrial membrane potential and an increase in mitochondrial membrane 
permeability.  This can be confirmed in the confocal images after that dose that no longer 
show fluorescently labeled mitochondria.  When comparing the differences in rate of 
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decrease in mitotracker red intensity, it was observed that Control cells and 30% MNP 
loaded cells acted similarly (p>0.05) while 10% and 70% MNPs acted similarly (p>0.05), 
with the control cells and 30% MNP loaded cells reacting more strongly to the CCCP 
than that of the 10% and 70% loaded cells.  After an initial dose of 0.6 µM CCCP 
mitochondria responded to the stimuli and did not recover enough before the final 1.4 µM 
CCCP dose that caused complete depolarization.  While all control and loaded cells 
eventually showed signs of complete depolarization the control and 30% MNP cells 
responded at a much faster rate than that of 10% and 70% loaded cells.  These results 
indicate that while the mitochondria of the loaded BAECs are still functioning, since we 
do see a response to CCCP aided uncoupling, there does not seem to be an correlation to 
MNP loadings and mitochondrial response. 
4.4.3 Actin Imaging 
Cytoskeletal microfilaments such as actin are important in cellular attachment and 
shape, therefore, we used transfection to stain β-actin in control and 12 hour 10%, 30% 
and 70% MNP loaded cells to determine if MNP loading had an affect on microfilament 
organization.  While not much work has been done in regards to MNP uptake effects on 
cytoskeletal organization, prior work has demonstrated that ultra-small MNP loading 
decreases microfilament organization within a cell [85, 86].  However, our results 
indicate that in comparison to control cells, 10% and 30% loaded cells after 12 hours did 
not show any altered cell morphology or difference in cytoskeletal organization.  70% 
loaded cells however, did show slightly rounder cell morphology with fewer cytoplasmic 
extensions in comparison to controls.  However, these effects can be assumed to be 
minimal, as they did not alter the cells ability to remain attached to the plate that they 
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were seeded in. The difference in our results and prior work showing severely altered 
microfilament organization lies in the size difference in particles used.  It has previously 
been indicated that MNPs of smaller sizes are more toxic to cells than those of larger 
sizes.  Given the difficulty in seeing the difference in actin organization in control and 
loaded cells, migration assays were performed in order to confirm whether or not 
cytoskeletal functionality was altered. 
4.4.4 Cytoskeletal Function – 2-D Migration 
It was expected that the high loading of MNPs exhibited after 12 hours of MNP 
uptake into BAECs would affect the ability for cells to migrate over a flat surface; 
however, our results showed that MNP uptake into cells significantly increased cell 
migration for 10% (p <0.0001), 30% (p <0.0001) and 70% (p <0.0001) in comparison to 
control.  The increase in migration rate with MNP loading can potentially be described in 
a few ways, with further research necessary to fully elucidate the actual mechanism.  
Previous work has suggested that MNP incorporation into endothelial cells causes 
intercellular gaps to form [93].  Given that BAEC growth and migration is contact 
inhibited, an increase in intercellular gap distance, by either shrinkage of the cell or some 
other method would signal for the cell to grow and/or migrate, despite the cell number 
being similar to that of control cells. Our loaded cells do exhibit a slight shrinkage that is 
only noticeable under the microscope that could be the cause of the observed increase in 
migration of cells.  Similarly, another potential theory for the enhanced migration is 
shown in research that reports MNP uptake of similar size as ours indicates a decrease in 
intercellular gap junction communication, which would again affect the contact inhibited 
nature of our BAECs [146].  This work suggests that stress kinases and β-catenin levels 
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modulate the alterations in intercellular gap junction communication.  This implies that 
the exposure of cells to MNPs induces a stress response that ends with a down regulation 
of intercellular signaling. Overall, these are two theories as to why uptake of MNPs into 
BAECs causes an increase in migration; however, further investigation is needed to 
determine whether these cellular responses are chronic or they are alleviated once cellular 
MNP concentration is diluted after cell division.  
4.4.5 Model Targeting – 3-D Migration 
 Three-Dimensional migration experiments have been conducted using a standard 
Boyden Chamber Assay of MNP loaded cells in the past [85].  Similarly, MNP loaded 
cells have been targeted in vitro to tissues for cell attachment [147] and even to 
implants[47, 50] however, MNP-loaded cells as targeted cell delivery/targeting vectors 
can be even more promising if we can characterize and manipulate their movement 
through tissues.  As a first step in order to eliminate the idiosyncrasies of transport 
through soft tissues, it is necessary to determine how MNP-loaded endothelial cells can 
navigate through a membrane with or without an applied magnetic field.  Our 3-D 
migration experiments of MNP-loaded endothelial cells through a transwell membrane 
show that not only are maximally loaded 70% MNP loaded cells capable of migrating, 
but there is a significant (p<0.001) increase in migration of MNP-loaded endothelial cells 
under the influence of a magnetic field to the point that MNP loaded cells exposed to a 
magnet without an FBS gradient have the same migration amount as non-loaded cells 
with a FBS gradient.  
 Control cells were seeded on the Transwell membrane with either a directional 
gradient in FBS concentration or no gradient in FBS concentration.  Control cells with a 
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directional gradient in FBS were the positive control and exhibited an increase in 
migration (p<0.001) of two and two and a half times in comparison to control 
cells ,whose apical and basal chambers were comprised of cell culture media of the same 
concentration of FBS for both 12 and 24 hour time points respectively. MNP loaded 
endothelial cells exposed to a magnet without an FBS gradient exhibited the same 
(p=0.57) migratory patterns as those of control cells with an FBS gradient.  This result 
suggests that the magnetic force does in fact encourage a migratory response in MNP-
loaded cells.  
MNP-loaded BAECs not exposed to a magnetic field responded the same (p=0.188) as 
control cells both with and without a concentration gradient of FBS, indicate that the 
magnetic field was causing the effect and not just the presence of the MNPs.  To be 
certain that these were migratory affects and not affects of increased proliferation as a 
result of MNP loading, alamar blue was conducted at 12 hour and 24 hour timepoints.  
Alamar blue at the 24 hour timepoints indicated that there were approximately 125,000 
cells/transwell for wells that did not show a concentration gradient and approximately 
135,000 for cells that did show a concentration gradient.  These values both correlate 
with the 0.5 population doublings/day that is suggested for bovine aortic endothelial cells.  
There was not however an increase between magnetically loaded and non-magnetically 
loaded cells, indicating that the increase in migration was not an affect of an increase in 
proliferation.  Overall, these results are promising indicators that magnetically loaded 
cells can be adequate targeted therapy delivery vectors in soft tissues.  
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4.5 Conclusion 
Biodegradable MNPs were formulated with variable loading of magnetite in a 
range of 10-70% (w/w) and loaded into bovine aortic endothelial cells under the 
influence of a magnetic field.  Confocal images show that 10% and 30% MNPs incubated 
with bovine aortic endothelial cells after one hour are not in fact internalized but merely 
associated with the endothelial cell membrane.  On the contrary, images of 30% and 70% 
MNP loaded cells display endothelial cells that are highly loaded during maximal 
incubation times. An analysis of cytoskeletal organization, microfilament function and 
mitochondrial health were performed, and we found no severe indications that these 
loadings were detrimental to cell health. 
These few, yet important characteristics of cell health, along with previous 
Alamar blue and calcein green studies demonstrate relatively healthy endothelial cells, 
despite the massive MNP loadings. Furthermore, while more investigation is needed to 
fully elucidate the effect of MNPs on sub-cellular organelle functions, it appears that 
MNP loadings do not affect the mitochondrial, cell division or migratory functional 
levels of the BAEC.  The ability to have maximal MNP loading allows the cells to be 
more magnetically responsive which increases their attractiveness as potential targeted 
drug delivery vectors, in addition to their innate biocompatibility 
It was expected that the high loading of MNPs exhibited after 12 hours of MNP 
uptake into BAECs would affect the ability for cells to migrate over a flat surface, 
however, our results showed that MNP uptake into cells significantly increased cell 
migration for 10% (p <0.0001), 30% (p <0.0001) and 70% (p <0.0001) in comparison to 
control.  The increase in migration rate with MNP loading can potentially be described in 
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a few ways, with further research necessary to fully elucidate the actual 
mechanism.  Previous work has suggested that MNP incorporation into endothelial cells 
causes intercellular gaps to form [93].  Given that BAEC growth and migration is contact 
inhibited, an increase in intercellular gap distance, by either shrinkage of the cell or some 
other method would signal for the cell to grow and/or migrate, despite the cell number 
being similar to that of control cells. Our loaded cells do exhibit a slight shrinkage that is 
only noticeable under the microscope that could be the cause of the observed increase in 
migration of cells.  Similarly, another potential theory for the enhanced migration is 
shown in research that reports MNP uptake of similar size as ours indicates a decrease in 
intercellular gap junction communication, which would again affect the contact inhibited 
nature of our BAECs (Ale-Agha, Albrecht et al. 2010).  This work suggests that stress 
kinases and β-catenin levels modulate the alterations in intercellular gap junction 
communication.  This implies that the exposure of cells to MNPs induces a stress 
response that ends with a down regulation of intercellular signaling. Overall, these are 
two theories as to why uptake of MNPs into BAECs causes an increase in migration, 
however, further investigation is needed to determine whether these cellular responses are 
chronic or they are alleviated once cellular MNP concentration is diluted after cell 
division.  
      Three-Dimensional migration experiments have been conducted using a standard 
Boyden Chamber Assay of MNP loaded cells in the past [85].  Similarly, MNP loaded 
cells have been targeted in vitro to tissues for cell attachment[147] and even to implants 
[47, 50] however, MNP-loaded cells as targeted cell delivery/targeting vectors can be 
even more promising if we can characterize and manipulate their movement through 
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tissues.  As a first step in order to eliminate the idiosyncrasies of transport through soft 
tissues, it is necessary to determine how MNP-loaded endothelial cells can navigate 
through a membrane with or without an applied magnetic field.  Our 3-D migration 
experiments of MNP-loaded endothelial cells through a transwell membrane show that 
not only are maximally loaded 70% MNP loaded cells capable of migrating, but there is a 
significant (p<0.001) increase in migration of MNP-loaded endothelial cells under the 
influence of a magnetic field.  
      Control cells were seeded on the Transwell membrane with either a directional 
gradient in FBS concentration or no gradient in FBS concentration.  Control cells with a 
directional gradient in FBS were the positive control and exhibited an increase in 
migration (p<0.001) of two and two and a half times in comparison to control cells that 
whose apical and basal chambers were comprised of cell culture media of the same 
concentration of FBS for both 12 and 24 hour time points respectively. MNP loaded 
endothelial cells exposed to a magnet without an FBS radient exhibited the same (p=0.57) 
migratory patterns as those of control cells with an FBS gradient.  This result suggests 
that the magnetic force does in fact encourage a migratory response in MNP-loaded cells. 
MNP-loaded BAECs not exposed to a magnetic field responded the same (p=0.188) as 
control cells both with and without a concentration gradient of FBS, indicate that the 
magnetic field was causing the effect and not just the presence of the MNPs.  To be 
certain that these were migratory affects and not affects of increased proliferation as a 
result of MNP loading, alamar blue was conducted at 12 hour and 24 hour 
timepoints.  Alamar blue at the 24 hour timepoints indicated that there were 
approximately 125,000 cells/transwell for wells that did not show a concentration 
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gradient and approximately 135,000 for cells that did show a concentration 
gradient.  These values both correlate with the 0.5 population doublings/day that is 
suggested for bovine aortic endothelial cells.  There was not however an increase 
between magnetically loaded and non-magnetically loaded cells, indicating that the 
increase in migration was not an affect of an increase in proliferation.  Overall, these 
results are promising indicators that magnetically loaded cells can be adequate targeted 
therapy delivery vectors in soft tissues. 
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Chapter 5: Conclusions and Future Work 
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5.1 Magnetic Nanoparticle Synthesis and Movement 
5.1.1 Summary of Principle Findings   Our study showed that it was possible to incorporate up to 70% (w/w) iron oxide  into  biodegradable  magnetic  nanoparticles  without  affecting  MNP  size distribution  or  surface  properties.    By  doing  so  we  were  able  to  increase  the magnetic  susceptibility  of  the  MNPs.    The  increase  in  magnetic  saturation  was linearly correlated with the percentage of the iron oxide loading.   
Our study used a model system with viscous  fluid to analyze how magnetic nanoparticles  of  various  loadings  would  move  through  viscous  fluid  with  the addition of an alternating magnetic field perpendicular to a gradient field provided by  a  permanent magnet.    The  theory was  that  the magnetic  nanoparticles  would move  faster with  this  small  “shaking”  field  since  it  helped  them  to  overcome  the initial  static  force.    Our  study  showed  that  the  time‐varying  magnetic  field superimposed onto the permanent gradient field is in fact a promising approach to enhance transport of magnetic carriers in soft media.  
5.1.2. Implications of the Current Study 
In recent years, much research has been completed on how magnetic 
nanoparticles can help with drug delivery and therapeutic treatments. While many of 
these studies have examined the aspects of MNPs formulation, characterization and drug 
release, actual work on how to target, deliver or transport the particles to the treatment 
area has been lacking. Thus it is important to understand the fundamental mechanisms by 
which MNPs can be actively transported through biological tissues under the action of a 
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magnetic field. MNPs can be carriers of various treatment modalities such as drugs, 
genes, radioactivity, and hyperthermia. Improved insight into the MNPs transport and 
actively-controlled soft tissue penetration is essential for improving the efficacy of 
current therapeutic methods for cancer, transport of drugs through Blood Brain Barrier 
(BBB), wound healing, cardiovascular disease, and many other pressing medical 
problems to which nanoparticulate drug delivery approach is applicable. 
Even if locomotion of carriers is difficult to achieve, the use of a time-varying uniform 
magnetic field superimposed onto the permanent gradient field may dramatically improve 
transport of carriers through soft tissues and their delivery to the target. The present study 
shows that, when applied correctly, time varying magnetic field could create oscillating 
force on the carriers which will reduce effective yield stresses which prevent the carriers 
from moving and, possibly, decrease effective viscous drag in tissues. Alternatively, the 
magnetic targeting can be enhanced by changing the effective resistance of the biological 
tissues, for example, by using magnetic carriers with proteolytic surface functionalization 
to increase carrier’s mobility through the extracellular matrix, as was shown in vitro 
[118] or through the inertial cavitation created by ultrasound, as has been shown in 
transdermal drug delivery [148, 149].  
 Our results on the effects of a time-varying uniform magnetic field superimposed 
on the permanent gradient field on the transport of MNPs demonstrate the potential of 
this approach to achieve more effective and controllable delivery of therapeutic agents or 
therapeutic effects. Hopefully this will lead to exploitation of the potential ability of this 
methodology to improve the delivery of the therapeutic agents/effects in vivo and in 
future clinical settings.    
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5.2 Magnetic Nanoparticle Uptake 
5.2.1 Summary of Principle Findings Our  results  showed  that  there  was  a  significant  increase  in  uptake  of magnetic nanoparticles under the influence of a magnetic field.    Indicating a force‐dependent mechanism of uptake.   MNP exposure  to  a magnetic  field  for one hour allows  complete  sedimentation  of  the  nanoparticles  to  the  cell  surface,  however, removal of the field results in a plateau in the amount of MNP uptake over a 12 hour period.  This shows that the increase in uptake when exposed to the magnet is not a result of  faster  initiation  to  the cell’s membrane.    In non‐treated cells, MNPs were loaded  into  cells  and  incorporated  up  to  15%  of  the  cells  volume.    Preliminary toxicity studies utilizing calcein green and alamar blue show that  the cells are not significantly affected by these high loadings.   
While our results indicate that there is certainly a force related mechanism of uptake,  the  exact mechanism  is  still  unknown.  Previous  studies  demonstrate  that cholesterol depletion is a way to block caveolae‐mediated endocytosis. MNP uptake after  cholesterol  depletion  results  in  no  change  in MNP  uptake.    On  the  contrary, cytochalasin  –D  treatment  of  cells,  historically  used  to  block  phagocytosis,  blocks almost all uptake of MNPs.  These results suggest that our particles are in fact taken up  via  a  phagocytotic  mechanism  that  is  enhanced  with  the  magnetic  forces presented on  the  cell membrane.     As with  all  endocytotic  studies,  altering  a  cells normal function, similar to what we do in these studies via cholesterol depletion or inhibition  of  actin  polymerization,  can modify  how  a  cell would  normally  process 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particles.    Therefore  further  research  and  newer  technologies  are  needed  to determine with greater certainty the uptake mechanism. 
5.2.2 Implications of the Current Study   Cellular  uptake  studies  involving  particles  typically  fall  into  one  of  two categories:  non‐magnetic  nanoparticle  endocytotic  pathway  studies  or  magnetic nanoparticle  transfection  studies.    This  study  combines  these  two  ideas  by examining  the  effect  a  magnetic  field  has  on  how  bovine  aortic  endothelial  cells uptake  MNPs.    Similarly,  the  uptake  of  these  MNPs  in  previous  studies  looks  at cellular health with MNP concentrations much lower than we show in our study.   
  The ability to load high concentrations of MNPs into a cell with low toxicity effects  allows  us  to  have  a  drug  delivery  vector  that  is  much  more  magnetically responsive  and  therefore  easier  to  target.    Similarly,  the  large  concentrations  are beneficial in hyperthermia applications, as there is more magnetic material located in the targeted area.  Overall, our study is novel in that it shows that endothelial cells survive  after  24  hours  with  high  loadings  of  high  magnetite  concentration nanoparticles. 
5.3 Loaded Endothelial Cells for Magnetic Targeting 
5.3.1 Summary of Principle Findings 
  Confocal  imaging  of  loaded  cells  showed  endothelial  cells  that were  highly loaded with MNPs.  These images made it difficult to believe that the cells were still functioning  and  not  “suffocating”.    Analysis  of  the  mitochondrial  membrane potentials  showed  that despite  an  increase  in  actively  respiring mitochondria,  the 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mitochondrial response to additional damages was similar in control cells and MNP loaded  cells,  indicating  that  there was no  severe damage done by  the presence of MNPs. 
  Similarly,  despite  high  loadings  of  MNPs  shown  in  confocal  images,  actin filaments  were  visualized  and  did  not  show  any  major  deformities.    Analysis  of cytoskeletal function by trypsinization and re‐seeding indicated that the cells ability to  attach was  not  affected.    Similarly,  migration  assays  indicate  that MNP  loaded cells are not only still capable of migrating, but do so at a faster velocity than that of the  control  cells.    Lastly,  we  were  able  to  show  that  we  can  manipulate  the movement  of  magnetically  loaded  endothelial  cells  through  a  membrane  in  the presence of a magnetic gradient provided by a permanent magnet.   
5.3.2 Implications of the Current Study 
Currently, there are multiple approaches to targeted therapies being researched that 
involve the use of magnetic micro/nanoparticles. Their high biocompatibility as a result 
of magnetite’s composition and the ability to position the magnetite in biocompatible 
polymer coatings such as PLA and PLGA [14, 24] makes them a potential resource for 
cancer treatment and gene delivery. Magnetic targeting utilizes an external magnetic field 
in combination with MNPs to allow delivery of particles to the desired target area and 
fixation to a local site while the medication is released and acts locally [24]. This 
technique allows for decreased dosage of chemical therapies that may otherwise cause 
deleterious systemic effects.   
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This method has been demonstrated successfully in treatments for cardiovascular 
diseases, as the simplistic nature of the vasculature leads to a straightforward model. The 
success of this treatment has contributed to the optimistic views on magnetic drug 
targeting in other areas of the body. While studies outside of the cardiovascular system 
are few, there has been some success shown in in-vitro models of mobilizing MNPs 
through simulated soft tissues [53, 57, 120, 121].  Our work is a first step in showing that  magnetically  loaded  cells  are  promising  vectors  for  targeted  drug  delivery through soft tissues.  We take the success of our colleagues and take it a step further by showing that loaded MNPs into cells not only does not affect cellular function but that we can also manipulate the movement of these cells through a simulated “tissue model”. 
The other benefit of our system is toxicity.  It has been shown that larger scale 
nanoparticles (>200nm) have a less toxic effect on the human body, therefore loaded cells 
with nanoparticles would have a significantly less toxic effect, since the body sees the 
cell and not the nanoparticles themselves.  The loaded cells do not allow MNPs to float 
freely throughout the body and the MNP concentration is diluted each time the cell 
divides.  Therefore, the body eliminates them more gradually.   
5.4  Future Work There  are  a  number  of  potential  studies  that  can  result  from  this  work.  Magnetic  targeting  is  still  a  hot  topic  in  biomedical  engineering  and  the  ability  to show successful targeting is a very publishable body of research, possibly even more so than functionalization of magnetic nanoparticles.  This work lays the groundwork for further tests of MNP loaded cell delivery. 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Our work  is  unique  in  that  the MNP  concentrations we  expose  the  cells  to results in equally high magnetic loadings with minimal negative effects.  Therefore, further transport studies of these cells should be conducted to show if the indication that  loaded  cells  have  higher  magnetic  susceptibilities  translates  to  a  better‐targeted  delivery  option  than  MNPs  on  their  own.    A  similar  study  to  the  3‐D migration we performed can be completed with a FluoroBlok tumor invasion assy.   This  assay  involves  the  same  setup  we  used  with  the  addition  of  a  BD  matrigel matrix on the apical part of the chamber.  Using this system would be the next step in mimicking  a  tissue  type  that  magnetically  targeted  drug  delivery  is  looking  to treat. 
Another interesting study that could be completed if  the correct alternating coil  could  be  produced  would  be  to  complete  the  magnetically  loaded  cell manipulation studies with the addition of the “vibrating” field present perpendicular to the direction of movement.  One would assume that a soft‐tissue is a matrix like structure that does now allow a straight path of travel for the MNP loaded cell.  The path that a loaded cell would have to follow would most likely be a zigzag pattern.  The  “vibrating  field” methodology  that  showed  promise  in  Chapter  2  could more effectively  guide  the  loaded  cells  through  the  intercellular  pathways  and  cell junctions of a soft tissue. 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